Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.
M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger
Title and authors | Publication | Year |
---|---|---|
Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus.
Szczepanska-Sadowska E |
International journal of molecular sciences | 2024 |
Alternative Renin-Angiotensin System.
Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM |
2024 | |
Delayed Graft Function and the Renin-angiotensin System.
Yamani F, Cianfarini C, Batlle D |
Transplantation | 2024 |
The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke
Olschewski DN, Nazarzadeh N, Lange F, Koenig AM, Kulka C, Abraham JA, Blaschke SJ, Merkel R, Hoffmann B, Fink GR, Schroeter M, Rueger MA, Vay SU |
BMC neuroscience | 2024 |
Immune and Metabolic Mechanisms of Endothelial Dysfunction
Kopaliani I, Elsaid B, Speier S, Deussen A |
International Journal of Molecular Sciences | 2024 |
Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers
Koumallos N, Sigala E, Milas T, Baikoussis NG, Aragiannis D, Sideris S, Tsioufis K |
International journal of molecular sciences | 2023 |
Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19.
Ghimire B, Pour SK, Middleton E, Campbell RA, Nies MA, Aghazadeh-Habashi A |
Biomedicines | 2023 |
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C |
Pharmacological reviews | 2022 |
AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells.
Mishra JS, Chen DB, Kumar S |
PloS one | 2022 |
Role of angiotensin II in aging
Yi W, Chen F, Zhang H, Tang P, Yuan M, Wen J, Wang S, Cai Z |
Frontiers in aging neuroscience | 2022 |
Zebrafish heart regeneration after coronary dysfunction-induced cardiac damage
Sun J, Peterson EA, Jiao C, Chen X, Zhao Y, Wang J |
Developmental Biology | 2022 |
Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
ME Mehrabadi, R Hemmati, A Tashakor, A Homaei, M Yousefzadeh, K Hemati, S Hosseinkhani |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
Polarized Proteins in Endothelium and Their Contribution to Function
AG Wolpe, CA Ruddiman, PJ Hall, BE Isakson |
Journal of Vascular Research | 2021 |
A role for aldehyde dehydrogenase (ALDH) 2 in angiotensin II-mediated decrease in angiogenesis of coronary endothelial cells
B Roy, SS Palaniyandi |
Microvascular Research | 2021 |
Secondary Metabolites of Plants as Modulators of Endothelium Functions
A Bartáková, M Nováková |
International journal of molecular sciences | 2021 |
Differences in the expression of the renin angiotensin system and the kallikrein-kinin system during the course of myocardial infarction in male and female Wistar rats
J Flores-Monroy, D Lezama-Martínez, S Fonseca-Coronado, L Martínez-Aguilar |
Journal of Renin-Angiotensin-Aldosterone System | 2020 |
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
N Singhania, S Bansal, S Mohandas, DP Nimmatoori, AA Ejaz, G Singhania |
Drugs in Context | 2020 |
The Therapeutic Potential of Angiotensin-converting Enzyme and Angiotensin Receptor Inhibitors in the Treatment of Colorectal Cancer: Rational Strategies and Recent Progress
F Asgharzadeh, SM Hassanian, GA Ferns, M Khazaei, M Hasanzadeh |
Current pharmaceutical design | 2019 |
The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction
K Dizaye, ZA Mustafa |
The Journal of pharmacy and pharmacology | 2019 |
BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition
W Han, Y Zhang, C Niu, J Guo, J Li, X Wei, M Jia, X Zhi, L Yao, D Meng |
Cancer Letters | 2019 |
Anti‐fibrotic mechanisms of angiotensin AT 2 ‐receptor stimulation
C Sumners, AA Peluso, AH Haugaard, JB Bertelsen, UM Steckelings |
Acta physiologica (Oxford, England) | 2019 |
Interplay between intracellular loop 1 and helix VIII of the angiotensin II type 2 receptor controls its activation
A Connolly, BJ Holleran, É Simard, JP Baillargeon, P Lavigne, R Leduc |
Biochemical Pharmacology | 2019 |
Renin angiotensin system and its role in biomarkers and treatment in gliomas
A Perdomo-Pantoja, SI Mejía-Pérez, L Gómez-Flores-Ramos, M Lara-Velazquez, C Orillac, JL Gómez-Amador, T Wegman-Ostrosky |
Journal of Neuro-Oncology | 2018 |
Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R
D Haspula, MA Clark |
The Journal of pharmacology and experimental therapeutics | 2018 |
Disorders of Blood Pressure Regulation
AE Berbari, G Mancia |
2018 | |
AT1 expression in human urethral stricture tissue
S Siregar, A Parardya, J Sibarani, T Romdan, K Adi, BS Hernowo, A Yantisetiasti |
Research and Reports in Urology | 2017 |
Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis
W Asghar, A Aghazadeh-Habashi, F Jamali |
Inflammopharmacology | 2017 |
Angiotensin II receptors’ modulation of calcium homeostasis in human vascular endothelial cells
M Kamal, D Jacques, G Bkaily |
Canadian Journal of Physiology and Pharmacology | 2017 |
Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism
Y Chang, Y Li, N Ye, X Guo, Z Li, G Sun, Y Sun |
International journal of molecular medicine | 2017 |
Difference in the response to angiotensin II between left and right ventricular endocardial endothelial cells
D Jacques, NA Abdel-Malak, NA Abdallah, J Al-Khoury, G Bkaily |
Canadian Journal of Physiology and Pharmacology | 2017 |
Targeting vasoactive peptides for managing calcific aortic valve disease
T Peltonen, P Ohukainen, H Ruskoaho, J Rysä |
Annals of Medicine | 2016 |
Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system: Regulation of CRC cell migration by the RAS
L Nguyen, EI Ager, J Neo, C Christophi |
Journal of Gastroenterology and Hepatology | 2016 |
Attenuation of angiotensin type 2 receptor function in the rostral ventrolateral medullary pressor area of the spontaneously hypertensive rat
T Kawabe, M Iwasa, K Kawabe, HN Sapru |
Clinical and Experimental Hypertension | 2016 |
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]
Sadashiva S Karnik, Hamiyet Unal, Jacqueline R Kemp, Kalyan C Tirupula, Satoru Eguchi, Patrick M L Vanderheyden, Walter G Thomas |
Pharmacological reviews | 2015 |
Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism
H Takata, H Yamada, H Kawahito, S Kishida, D Irie, T Kato, N Wakana, S Miyagawa, K Fukui, H Matsubara |
Journal of Renin-Angiotensin-Aldosterone System | 2015 |
Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice
S Ishiguro, K Yoshimura, R Tsunedomi, M Oka, S Takao, M Inui, A Kawabata, T Wall, V Magafa, P Cordopatis, AG Tzakos, M Tamura |
Cancer biology & therapy | 2015 |
A revisit on the renin–angiotensin system in cardiovascular biology
XY Tian, S Ma, Y Huang, WT Wong |
Trends in Cardiovascular Medicine | 2015 |
Ketoconazole Treatment Decreases the Viability of Immortalized Pituitary Cell Lines Associated with an Increased Expression of Apoptosis-Related Genes and Cell Cycle Inhibitors
MF Guzzo, LR Carvalho, MD Bronstein |
Journal of Neuroendocrinology | 2015 |
Platelet–endothelial cell interaction in brain microvessels of angiotensin II type-2 receptor knockout mice following transient bilateral common carotid artery occlusion
T Fukuoka, T Hayashi, M Hirayama, H Maruyama, M Mogi, M Horiuchi, M Takao, N Tanahashi |
Journal of Thrombosis and Thrombolysis | 2015 |
The Protective Arm of the Renin Angiotensin System (RAS)
T Unger, UM Steckelings, VJ Dzau |
The Protective Arm of the Renin Angiotensin System (RAS) | 2015 |
Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors
T Kellici, A Tzakos, T Mavromoustakos |
Molecules (Basel, Switzerland) | 2015 |
AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray
NA Alhakamy, S Ishiguro, D Uppalapati, CJ Berkland, M Tamura |
Molecular cancer therapeutics | 2015 |
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli
Sadashiva S. Karnik, Hamiyet Unal, Jacqueline R. Kemp, Kalyan C. Tirupula, Satoru Eguchi, Patrick M. L. Vanderheyden, Walter G. Thomas |
Pharmacological reviews | 2015 |
Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli
SS Karnik, H Unal, JR Kemp, KC Tirupula, S Eguchi, PM Vanderheyden, WG Thomas |
Pharmacological reviews | 2015 |
Function and expression of ATIP and its variants in cardiomyoblast cell line H9c2
N Varghayee, MA Krezel, L Rezmann, L Chow, AG Frauman, WJ Louis, SN Louis |
Journal of Renin-Angiotensin-Aldosterone System | 2015 |
Developmental expression patterns for angiotensin receptors in mouse skin and brain
L Yu, C Shao, L Gao |
Journal of Renin-Angiotensin-Aldosterone System | 2014 |
Gene Expression Profiling Associated with Angiotensin II Type 2 Receptor-Induced Apoptosis in Human Prostate Cancer Cells
N Pei, F Jie, J Luo, R Wan, Y Zhang, X Chen, Z Liang, H Du, A Li, B Chen, Y Zhang, C Sumners, J Li, W Gu, H Li, G Qin |
PloS one | 2014 |
Systems Biology of Free Radicals and Antioxidants
I Laher |
2014 | |
Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells
M Liu, D Jing, Y Wang, Y Liu, S Yin |
Molecular and Cellular Biochemistry | 2014 |
How does the angiotensin II type 1 receptor ‘trump’ the type 2 receptor in blood pressure control?:
MA Schalekamp, AH Danser |
Journal of Hypertension | 2013 |
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure
LA Danyel, P Schmerler, L Paulis, T Unger, UM Steckelings |
Integrated Blood Pressure Control | 2013 |
Angiotensin II receptor antagonists in acute coronary syndromes
N Artom, F Montecucco, F Mach, F Dallegri, A Pende |
European Journal of Clinical Investigation | 2013 |
Hypoxia-Inducible Factor-1 in Vascular Smooth Muscle Regulates Blood Pressure Homeostasis Through a Peroxisome Proliferator-Activated Receptor- -Angiotensin II Receptor Type 1 Axis
Y Huang, AD Lorenzo, W Jiang, A Cantalupo, WC Sessa, FJ Giordano |
Hypertension | 2013 |
Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet
JR Karcher, AS Greene |
American journal of physiology. Cell physiology | 2013 |
Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis
D Okwan-Duodu, J Landry, XZ Shen, R Diaz |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2013 |
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
JS Silvestre, DM Smadja, BI Lévy |
Physiological reviews | 2013 |
Differential Mechanisms of Activation of the Ang Peptide Receptors AT1, AT2, and MAS: Using In Silico Techniques to Differentiate the Three Receptors
JW Prokop, RA Santos, A Milsted, M Bader |
PloS one | 2013 |
Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo
H Du, Z Liang, Y Zhang, F Jie, J Li, Y Fei, Z Huang, N Pei, S Wang, A Li, B Chen, Y Zhang, C Sumners, M Li, H Li, J Yue |
PloS one | 2013 |
Local Fetal Lung Renin-Angiotensin System as a Target to Treat Congenital Diaphragmatic Hernia
C Nogueira-Silva, E Carvalho-Dias, P Piairo, S Nunes, MJ Baptista, RS Moura, J Correia-Pinto |
Molecular Medicine | 2012 |
The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro
D Ptasinska-Wnuk, SA Mucha, H Lawnicka, J Fryczak, J Kunert-Radek, M Pawlikowski, H Stepien |
Endocrine | 2012 |
Impact of the AT2 Receptor Agonist C21 on Blood Pressure and Beyond
S Foulquier, UM Steckelings, T Unger |
Current Hypertension Reports | 2012 |
Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium
J Carbajo-Lozoya, S Lutz, Y Feng, J Kroll, HP Hammes, T Wieland |
Cellular Signalling | 2012 |
Angiotensin II type 2 receptor agonists: where should they be applied?
K Verdonk, AH Danser, JH van Esch |
Expert Opinion on Investigational Drugs | 2012 |
Muscle
ML Martin, SL Belmonte, R Ram, FA Kamal, BC Blaxall |
Muscle | 2012 |
Update on the Angiotensin AT2 Receptor
CA McCarthy, RE Widdop, KM Denton, ES Jones |
Current Hypertension Reports | 2012 |
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
P Namsolleck, F Boato, K Schwengel, L Paulis, K Matho, N Geurts, C Thöne-Reineke, K Lucht, K Seidel, A Hallberg, B Dahlöf, T Unger, S Hendrix, UM Steckelings |
Neurobiology of Disease | 2012 |
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth
A Kawabata, A Baoum, N Ohta, S Jacquez, GM Seo, C Berkland, M Tamura |
Cancer research | 2012 |
Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries
AJ McNeish, F Jimenez-Altayo, GS Cottrell, CJ Garland |
PloS one | 2012 |
A Non-peptide Angiotensin II Type 2 Receptor Agonist Does Not Attenuate Post-Myocardial Infarction Left Ventricular Remodeling in Mice
AB Jehle, Y Xu, JM DiMaria, BA French, FH Epstein, SS Berr, RJ Roy, BA Kemp, RM Carey, CM Kramer |
Journal of Cardiovascular Pharmacology | 2012 |
A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex
B Peters, D Podlich, M Ritter, A Müller, H Wanka, C Maser-Gluth, C Seitz, L Boni, E Maier, N Gretz, J Peters, SC Hoffmann |
American journal of physiology. Endocrinology and metabolism | 2012 |
Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation
J Kim, HJ Jang, LA Martinez-Lemus, JR Sowers |
American journal of physiology. Endocrinology and metabolism | 2012 |
Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4
YC Kim, RM Day |
American journal of physiology. Lung cellular and molecular physiology | 2012 |
The effect of losartan on angiotensin II-induced cell proliferation in a rat aorta smooth muscle cell line
N Tambelline, K Oliveira, LR Olchanheski, R Sordi, MF Otuki, GM Favero, D Fernandes |
Brazilian Archives of Biology and Technology | 2012 |
Genetically Modified Mouse Models Used for Studying the Role of the AT 2 Receptor in Cardiac Hypertrophy and Heart Failure
MD Avila, JP Morgan, X Yan |
Journal of Biomedicine and Biotechnology | 2011 |
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury: Cardioprotection by overexpression of AT 2 receptors
Y Qi, H Li, V Shenoy, Q Li, F Wong, L Zhang, MK Raizada, C Sumners, MJ Katovich |
Experimental Physiology | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: Challenges in Comparative Effectiveness Using Medicare Data
S Setoguchi, WH Shrank, J Liu, JC Lee, U Saya, WC Winkelmayer, NA Dreyer |
Clinical Pharmacology & Therapeutics | 2011 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation
EI Ager, SW Wen, J Chan, WW Chong, JH Neo, C Christophi |
BMC Cancer | 2011 |
Valsartan plus hydrochlorothiazide: a review of its use since its introduction
J Bains, WB Smith |
Expert Opinion on Pharmacotherapy | 2011 |
Non-peptide AT2-receptor agonists
UM Steckelings, M Larhed, A Hallberg, RE Widdop, ES Jones, C Wallinder, P Namsolleck, B Dahlöf, T Unger |
Current Opinion in Pharmacology | 2011 |
Postnatal early overnutrition dysregulates the intrarenal renin–angiotensin system and extracellular matrix-linked molecules in juvenile male rats
HE Yim, KS Ha, IS Bae, KH Yoo, YS Hong, JW Lee |
The Journal of Nutritional Biochemistry | 2011 |
Chronic inflammation and atherosclerosis : A critical role for renin angiotensin system that is activated by lifestyle-related diseases
M Sata, D Fukuda |
Inflammation and Regeneration | 2011 |
The Effect of Selective Antihypertensive Drugs on the Vascular Remodeling-associated Hypertension: Insights From a Profilin1 Transgenic Mouse Model
MD Hassona, MT Elnakish, ZA Abouelnaga, M Alhaj, AA Wani, H Hassanain |
Journal of Cardiovascular Pharmacology | 2011 |
Clinical utility of valsartan in the treatment of hypertension in children and adolescents
R Baracco, G Kapur |
Patient preference and adherence | 2011 |
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro
L Ren, N Liu, H Zhi, Y Li, Y Li, R Tang, Z Sheng |
Cardiovascular Diabetology | 2011 |
Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness
LN Agbor, KM Elased, MK Walker |
Biochemical Pharmacology | 2011 |
MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension
G Castoldi, CR di Gioia, C Bombardi, D Catalucci, B Corradi, MG Gualazzi, M Leopizzi, M Mancini, G Zerbini, G Condorelli, A Stella |
Journal of Cellular Physiology | 2011 |
Fetal and Neonatal Physiology
LH Johnson, VK Bhutani |
Fetal and Neonatal Physiology | 2011 |
Angiotensin Peptides and Lung Cancer
PE Gallagher, K Cook, D Soto-Pantoja, J Menon, EA Tallant |
Current cancer drug targets | 2011 |
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
C Doi, N Egashira, A Kawabata, DK Maurya, N Ohta, D Uppalapati, R Ayuzawa, L Pickel, Y Isayama, D Troyer, S Takekoshi, M Tamura |
BMC Cancer | 2010 |
Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
EI Ager, WW Chong, SW Wen, C Christophi |
Cancer Cell International | 2010 |
Angiogenesis and Melanoma
D Ribatti, T Annese, V Longo |
Cancers | 2010 |
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
L Shi, C Mao, Z Xu, L Zhang |
Drug Discovery Today | 2010 |
Telmisartan regresses left ventricular hypertrophy in caveolin-1 deficient mice
MH Krieger, AD Lorenzo, C Teutsch, K Kauser, WC Sessa |
Laboratory Investigation | 2010 |
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
NC Li, A Lee, RA Whitmer, M Kivipelto, E Lawler, LE Kazis, B Wolozin |
BMJ (Clinical research ed.) | 2010 |
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli |
Burger's Medicinal Chemistry and Drug Discovery | 2010 |
Textbook of Diabetes
PM Jones, SJ Persaud |
Textbook of Diabetes | 2010 |
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis
M Sata, D Fukuda |
The Journal of Medical Investigation | 2010 |
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium
T Hasin, O Elhanani, Z Abassi, T Hai, A Aronheim |
Basic Research in Cardiology | 2010 |
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T Dolley-Hitze, F Jouan, B Martin, S Mottier, J Edeline, O Moranne, PL Pogamp, MA Belaud-Rotureau, JJ Patard, N Rioux-Leclercq, C Vigneau |
British Journal of Cancer | 2010 |
Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase
JE Kim, HC Choi |
The Korean Journal of Physiology and Pharmacology | 2010 |
The angiotensin AT2 receptor in left ventricular hypertrophy
UM Steckelings, RE Widdop, L Paulis, T Unger |
Journal of Hypertension | 2010 |
Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells
MO Guimond, C Roberge, N Gallo-Payet |
Molecular and Cellular Neuroscience | 2010 |
Liver regeneration and tumour stimulation: implications of the renin-angiotensin system
SL Koh, EI Ager, C Christophi |
Liver International | 2010 |
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
JH Neo, EI Ager, PW Angus, J Zhu, CB Herath, C Christophi |
BMC Cancer | 2010 |
Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
L Pickel, T Matsuzuka, C Doi, R Ayuzawa, DK Maurya, SX Xie, C Berkland, M Tamura |
Cancer biology & therapy | 2010 |
Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1
M Menk, C Haefen, H Funke-Kaiser, M Sifringer, JH Schefe, S Kirsch, K Seidel, J Reinemund, UM Steckelings, T Unger, CD Spies |
Alcohol | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Comprehensive Toxicology
JM Sands, JW Verlander |
Comprehensive Toxicology | 2010 |
xPharm: The Comprehensive Pharmacology Reference
A Vinh |
xPharm: The Comprehensive Pharmacology Reference | 2010 |
Burden of illness among patients at high risk versus low risk for major cardiovascular events
C Harley, SD Sander, V Zarotsky, F Cao, H Shah |
Journal of Medical Economics | 2010 |
Developmental changes in AT1 and AT2 receptor-protein expression in rats
L Yu, M Zheng, W Wang, GJ Rozanski, IH Zucker, L Gao |
Journal of Renin-Angiotensin-Aldosterone System | 2010 |
Skeletal muscle-endothelial cell cross talk through angiotensin II
LM Bellamy, AP Johnston, MD Lisio, G Parise |
American journal of physiology. Cell physiology | 2010 |
The Promyelocytic Leukemia Zinc Finger (PLZF) Protein Exerts Neuroprotective Effects in Neuronal Cells and is Dysregulated in Experimental Stroke: Neuroprotective Effects of PLZF
K Seidel, S Kirsch, K Lucht, D Zaade, J Reinemund, J Schmitz, S Klare, Y Li, JH Schefe, K Schmerbach, P Goldin-Lang, FS Zollmann, C Thöne-Reineke, T Unger, H Funke-Kaiser |
Brain Pathology | 2010 |
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy
L Anton, DC Merrill, LA Neves, DI Diz, J Corthorn, G Valdes, K Stovall, PE Gallagher, C Moorefield, C Gruver, KB Brosnihan |
Endocrinology | 2009 |
MicroRNAs as novel regulators of angiogenesis
Y Suárez, WC Sessa |
Circulation research | 2009 |
Cytosolic renin is targeted to mitochondria and inducesapoptosis in H9c2 rat cardiomyoblasts
H Wanka, N Keßler, J Ellmer, N Endlich, BS Peters, S Clausmeyer, J Peters |
Journal of Cellular and Molecular Medicine | 2009 |
Cardiac c-kit+AT2+ Cell Population is Increased in Response to Ischemic Injury and Supports Cardiomyocyte Performance
W Altarche-Xifró, C Curato, E Kaschina, A Grzesiak, S Slavic, J Dong, K Kappert, M Steckelings, H Imboden, T Unger, J Li |
Stem Cells | 2009 |
Expression of angiotensin II and its receptors in the normal and hypoxic amoeboid microglial cells and murine BV-2 cells
JJ Li, J Lu, C Kaur, V Sivakumar, CY Wu, EA Ling |
Neuroscience | 2009 |
Inflammatory Corneal Neovascularization and Tissue Renin-Angiotensin System
T Usui, S Ishida, S Amano |
Cornea | 2009 |
The evolving story of the RAAS in hypertension, diabetes and CV disease ��� moving from macrovascular to microvascular targets
UM Steckelings, F Rompe, E Kaschina, T Unger |
Fundamental & Clinical Pharmacology | 2009 |
ANGIOTENSIN AT2RECEPTOR AS A POTENTIAL THERAPEUTIC TARGET IN HYPERTENSION
WT Wong, Y Huang |
Clinical and Experimental Pharmacology and Physiology | 2009 |
Cardiovascular Effects of Losartan and Its Relevant Clinical Application
F Xu, C Mao, Y Hu, C Rui, Z Xu, L Zhang |
Current medicinal chemistry | 2009 |
Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes
J Reinemund, K Seidel, UM Steckelings, D Zaade, S Klare, F Rompe, M Katerbaum, J Schacherl, Y Li, M Menk, JH Schefe, P Goldin-Lang, C Szabo, G Olah, T Unger, H Funke-Kaiser |
Biochemical Pharmacology | 2009 |
Adapter proteins and promoter regulation of the angiotensin AT2 receptor — implications for cardiac pathophysiology
H Funke-Kaiser, J Reinemund, UM Steckelings, T Unger |
Journal of Renin-Angiotensin-Aldosterone System | 2009 |
Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease
AJ Balmforth |
Journal of Renin-Angiotensin-Aldosterone System | 2009 |
Peptide Hormone Regulation of Angiogenesis
C Clapp, S Thebault, MC Jeziorski, GM de la Escalera |
Physiological reviews | 2009 |
The past, present and future of angiotensin II type 2 receptor stimulation
UM Steckelings, F Rompe, E Kaschina, P Namsolleck, A Grzesiak, H Funke-Kaiser, M Bader, T Unger |
Journal of Renin-Angiotensin-Aldosterone System | 2009 |
Renin Angiotensin System and Cardiovascular Disease
WC DeMello, ED Frohlich |
2009 | |
Red Wine Polyphenols Prevent Acceleration of Neovascularization by Angiotensin II in the Ischemic Rat Hindlimb
A Walter, N Etienne-Selloum, D Brasse, R Schleiffer, V Bekaert, PM Vanhoutte, A Beretz, VB Schini-Kerth |
The Journal of pharmacology and experimental therapeutics | 2009 |
AT2 receptors: Functional relevance in cardiovascular disease
ES Jones, A Vinh, CA McCarthy, TA Gaspari, RE Widdop |
Pharmacology & Therapeutics | 2008 |
Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation
MM de Resende, AS Greene |
American journal of physiology. Heart and circulatory physiology | 2008 |
Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
O Arrieta, B Pineda-Olvera, P Guevara-Salazar, N Hernández-Pedro, D Morales-Espinosa, TL Cerón-Lizarraga, CH la Rosa, D Rembao, B Segura-Pacheco, J Sotelo |
British Journal of Cancer | 2008 |
Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT2 receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung
M Tamura, H Yan, O Zegarra-Moro, J Edl, S Oursler, C Chard-Bergstrom, G Andrews, T Kanehira, S Takekoshi, R Mernaugh |
Journal Of Molecular Histology | 2008 |
Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
DP Macfarlane, KR Paterson, M Fisher |
Diabetes, Obesity and Metabolism | 2008 |
Role of bone marrow renin–angiotensin system in the pathogenesis of atherosclerosis
D Fukuda, M Sata |
Pharmacology & Therapeutics | 2008 |
Renin–angiotensin system–growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis
IV Yosypiv |
Pediatric Nephrology | 2008 |
Role of the Angiotensin II Type 2 Receptor in Arterial Remodeling after Wire Injury in Mice
Y YAMAMOTO, Y WATARI, A BRYDUN, M YOSHIZUMI, M AKISHITA, M HORIUCHI, K CHAYAMA, T OSHIMA, R OZONO |
Hypertension Research | 2008 |
Peroxisome proliferator-activated receptor α activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat
T Banks, A Oyekan |
Journal of Hypertension | 2008 |
Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells
K Nakai, K Yoneda, J Igarashi, T Moriue, H Kosaka, Y Kubota |
Journal of Dermatological Science | 2008 |
Nerve growth factor and brain-derived neurotrophic factor attenuate angiotensin-II-induced facilitation of calcium channels in acutely dissociated nucleus tractus solitarii neurons of the rat
T Endoh, D Sato, Y Wada, K Ishihara, S Hashimoto, M Yoshinari, K Matsuzaka, M Tazaki, T Inoue |
Archives of Oral Biology | 2008 |
The Johns Hopkins Manual of Cardiac Surgical Care
PK Simmonds, D Nyhan, DE Berkowitz |
The Johns Hopkins Manual of Cardiac Surgical Care | 2008 |
LESSONS FROM ONTARGET
V Berlaimont, JM Billiouw, C Brohet, AG Dupont, MD Gazagnes, F Heller, JM Krzesinski, L Missault, A Persu, L Piérard, R Rottiers, G Vanhooren, WV Mieghem, P Vervaet, AG Herman |
ACTA CLINICA BELGICA | 2008 |
Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT 2 receptors in ventricular myocytes
X Yan, AJ Schuldt, RL Price, I Amende, FF Liu, K Okoshi, KK Ho, AJ Pope, TK Borg, BH Lorell, JP Morgan |
American journal of physiology. Heart and circulatory physiology | 2008 |
Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation
MM de Resende, AS Greene |
American journal of physiology. Heart and circulatory physiology | 2008 |
Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats
JP Collister, DB Nahey |
Journal of Renin-Angiotensin-Aldosterone System | 2008 |
Angiogenesis in Inflammation: Mechanisms and Clinical Correlates
MP Seed, DA Walsh |
2008 | |
In Adrenal Glomerulosa Cells, Angiotensin II Inhibits Proliferation by Interfering with Fibronectin-Integrin Signaling
M Otis, S Campbell, MD Payet, N Gallo-Payet |
Endocrinology | 2008 |
Mechanisms of progression of chronic kidney disease
AB Fogo |
Pediatric Nephrology | 2007 |
Angiotensin-(1–7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT1–7 receptor
L Anton, DC Merrill, LA Neves, KB Brosnihan |
Endocrine | 2007 |
Nonclassic Endogenous Novel Regulators of Angiogenesis
D Ribatti, MT Conconi, GG Nussdorfer |
Pharmacological reviews | 2007 |
NO-cGMP and TNF-α counter regulatory system in blood: Understanding the mechanisms leading to myocardial dysfunction and failure
M Elahi, S Asopa, B Matata |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2007 |
Direct Inhibition of Renin as a Cardiovascular Pharmacotherapy
R Sepehrdad, WH Frishman, CT Stier, DA Sica |
Cardiology in Review | 2007 |
Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes
F Grover-Páez, GV Rivera, RG Ortíz |
Diabetes Research and Clinical Practice | 2007 |
Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide–containing nerves in rat mesenteric arteries
N Hobara, M Goda, N Yoshida, S Takatori, Y Kitamura, M Mio, H Kawasaki |
Neuroscience | 2007 |
Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (−1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization
K Alfakih, B Brown, RA Lawrance, P Warburton, A Maqbool, K Walters, NJ Samani, SG Ball, AJ Balmforth, AS Hall |
Atherosclerosis | 2007 |
Antihypertensive Combination Therapy: Optimizing Blood Pressure Control and Cardiovascular Risk Reduction
SD Nesbitt |
The Journal of Clinical Hypertension | 2007 |
Renin-angiotensin system and cardiovascular risk
RE Schmieder, KF Hilgers, MP Schlaich, BM Schmidt |
The Lancet | 2007 |
Effects of Angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response
B Kou, M Vatish, DR Singer |
Vascular Pharmacology | 2007 |
An update on non-peptide angiotensin receptor antagonists and related RAAS modulators
GK Aulakh, RK Sodhi, M Singh |
Life Sciences | 2007 |
Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor
A Tone, K Shikata, D Ogawa, S Sasaki, R Nagase, M Sasaki, K Yozai, HK Usui, S Okada, J Wada, Y Shikata, H Makino |
Journal of Renin-Angiotensin-Aldosterone System | 2007 |
Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes
T Bäcklund, P Lakkisto, E Palojoki, T Grönholm, A Saraste, P Finckenberg, E Mervaala, I Tikkanen, M Laine |
Journal of Renin-Angiotensin-Aldosterone System | 2007 |
Comparison of Selective AT 1 -Receptor Blockade Versus ACE Inhibition for Restenosis Prophylaxis in Patients With Peripheral Occlusive Arterial Disease After Stent Angioplasty: A Randomized, Controlled, Proof-of-Concept Study
C Schindler, A Mueller, P Bramlage, W Boecking, W Kirch, J Schweizer |
Angiology | 2007 |
Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reduction.
Nesbitt SD |
Journal of clinical hypertension (Greenwich, Conn.) | 2007 |
Physiology of local renin-angiotensin systems
M Paul, AP Mehr, R Kreutz |
Physiological reviews | 2006 |
Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
M Zhang, H Ma, B Wang, Y Zhao |
Heart and Vessels | 2006 |
No Evidence for Angiotensin Type 2 Receptor Gene Polymorphism in Intron 1 in Patients with Coarctation of the Aorta and Ullrich–Turner Syndrome
E Struwe, K Krammer, J Dötsch, M Metzler, HG Dörr, R Cesnjevar, W Rascher, A Koch |
Pediatric Cardiology | 2006 |
AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation
JH van Esch, MP Schuijt, J Sayed, Y Choudhry, T Walther, AH Danser |
British Journal of Pharmacology | 2006 |
AT&sub1; Receptor Blockade Prevents Microvascular Dysfunction Induced by Ischemia/Reperfusion Injury
K Akiyoshi, T Akimitsu, M Hara, T Saikawa, H Yoshimatsu |
Journal of Atherosclerosis and Thrombosis | 2006 |
Effect of candesartan on coronary flow reserve in patients with systemic hypertension
JP Tomás, JL Moya, V Barrios, R Campuzano, G Guzman, A Megías, S Ruiz-Leria, P Catalán, T Marfil, B Tarancón, A Muriel, A García-Lledó |
Journal of Hypertension | 2006 |
AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling
Y Oishi, R Ozono, M Yoshizumi, M Akishita, M Horiuchi, T Oshima |
Life Sciences | 2006 |
Angiotensin II-mediated apoptosis on human vascular smooth muscle cells
H Song, D Gao, L Chen, K Seta, JS McLaughlin, C Wei |
Journal of Cardiothoracic-Renal Research | 2006 |
Toxicité rénale des antiangiogéniques
C Vigneau, N Rioux-Leclercq |
EMC - Néphrologie | 2006 |
Inhibiteurs de l'enzyme de conversion et antagonistes du récepteur AT1r de l'angiotensine II
P Boutouyrie, S Laurent |
EMC - Cardiologie | 2006 |
Angiotensin II Receptor Antagonists: Current Perspectives
T Kurtz |
Angiotensin II Receptor Antagonists: Current Perspectives | 2006 |
Características farmacológicas de los ARA-II. ¿Son todos iguales?
J Tamargo, R Caballero, R Gómez, L Núñez, M Vaquero, E Delpón |
Revista Española de Cardiología Suplementos | 2006 |
The Diabetic Kidney
P Cortes, CE Mogensen |
2006 | |
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen
D Ganten, K Ruckpaul, J Köhrle |
2006 | |
AT2 Receptor Stimulation May Halt Progression of Pheochromocytoma
MJ Brown, IS Mackenzie, MJ Ashby, KK Balan, DS Appleton |
Annals of the New York Academy of Sciences | 2006 |
The Vascular Endothelium I
S Moncada, A Higgs |
2006 | |
Chronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density
DH Munzenmaier, AS Greene |
American journal of physiology. Heart and circulatory physiology | 2005 |
Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system
IV Yosypiv, SS El-Dahr |
Pediatric Nephrology | 2005 |
Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives
L Tylicki, W Larczynski, B Rutkowski |
Kidney and Blood Pressure Research | 2005 |
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
O Arrieta, P Guevara, E Escobar, R García-Navarrete, B Pineda, J Sotelo |
British Journal of Cancer | 2005 |
Differential Effects of Antihypertensive Drugs on Renal and Glomerular Hemodynamics and Injury in the Chronic Nitric-Oxide-Suppressed Rat
X Zhou, ED Frohlich |
American Journal of Nephrology | 2005 |
Tissue-Specific Expression of Renin-Angiotensin System Components in IgA Nephropathy
C Miyake-Ogawa, M Miyazaki, K Abe, T Harada, Y Ozono, H Sakai, T Koji, S Kohno |
American Journal of Nephrology | 2005 |
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf, T Lau, R Olsson, PS Leung, PO Carlsson |
Diabetologia | 2005 |
Differential expression of angiotensin receptors in human cutaneous wound healing
UM Steckelings, BM Henz, S Wiehstutz, T Unger, M Artuc |
British Journal of Dermatology | 2005 |
Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin–angiotensin system
X Guo, HK Saini, J Wang, SK Gupta, RK Goyal, NS Dhalla |
Expert Review of Cardiovascular Therapy | 2005 |
Angiotensin II receptor 2
S Sheikh, J Hansen |
AfCS-Nature Molecule Pages | 2005 |
Biphasic Effects of Losartan Potassium on Immobility in Mice
P VIJAYAPANDI, AN NAGAPPA |
YAKUGAKU ZASSHI | 2005 |
Telmisartan: from lowering blood pressure to end-organ protection
T Unger, M Schupp |
Future Cardiology | 2005 |
Valsartan in the treatment of hypertension
SE Kjeldsen, HR Brunner, GT McInnes, P Stolt |
Aging Health | 2005 |
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation
Y Zhao, A Foryst-Ludwig, D Bruemmer, J Culman, M Bader, T Unger, U Kintscher |
Journal of Neurochemistry | 2005 |
The AT2 receptor—A matter of love and hate
UM Steckelings, E Kaschina, T Unger |
Peptides | 2005 |
Ligand-dependent complex formation between the Angiotensin II receptor subtype AT2 and Na+/H+ exchanger NHE6 in mammalian cells
L Pulakat, S Cooper, D Knowle, C Mandavia, S Bruhl, M Hetrick, N Gavini |
Peptides | 2005 |
Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice
H Utsunomiya, M Nakamura, K Kakudo, T Inagami, M Tamura |
Regulatory Peptides | 2005 |
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure
M Blanchet, R Sheppard, N Racine, A Ducharme, D Curnier, JC Tardif, P Sirois, MC Lamoureux, JD Champlain, M White |
American Heart Journal | 2005 |
Effects of oral fixed-dose combinations of telmisartan plus ramipril and losartan plus ramipril in hypertension: A multicenter, prospective, randomized, double-blind, phase iii trial in adult indian patients
SD Jain, S Biradar, I Periyandavar, SS Sodhi, K Anwaruddin, A Gawde, V Baliga, K Gandewar, A Desai |
Current Therapeutic Research | 2005 |
Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide: Effects of Ang II on ovine fetoplacental endothelium
J Zheng, IM Bird, DB Chen, RR Magness |
The Journal of Physiology | 2005 |
Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing
C Warnecke, P Mugrauer, D Sürder, J Erdmann, C Schubert, V Regitz-Zagrosek |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2005 |
AT 2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT 1 receptor antagonism in conscious normotensive but not hypertensive rats
LM Duke, RG Evans, RE Widdop |
American journal of physiology. Heart and circulatory physiology | 2005 |
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT 1 -receptor blocker over thiazide alone on renoprotection in l -NAME/SHR
X Zhou, LC Matavelli, H Ono, ED Frohlich |
American journal of physiology. Renal physiology | 2005 |
ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain
A Blume, C Undeutsch, Y Zhao, E Kaschina, J Culman, T Unger |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2005 |
Constitutively Active Homo-oligomeric Angiotensin II Type 2 Receptor Induces Cell Signaling Independent of Receptor Conformation and Ligand Stimulation
S Miura, SS Karnik, K Saku |
The Journal of biological chemistry | 2005 |
Neuroprotection with Angiotensin Receptor Antagonists: A Review of the Evidence and Potential Mechanisms
H Wilms, P Rosenstiel, T Unger, G Deuschl, R Lucius |
American Journal Cardiovascular Drugs | 2005 |
Angiotensin Antagonism in Coronary Artery Disease: Results after Coronary Revascularisation
F Ribichini, V Ferrero, A Rognoni, G Vacca, C Vassanelli |
Drugs | 2005 |
Interstitial Fibrosis in Heart Failure
FJ Villarreal |
2005 | |
Mechanisms of Angiogenesis
M Clauss, G Breier |
2005 | |
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors
Y Kawaguchi, K Takagi, M Hara, C Fukasawa, T Sugiura, E Nishimagi, M Harigai, N Kamatani |
Arthritis & Rheumatism | 2004 |
Vascular angiotensin II actions mediated by angiotensin II type 2 receptors
RE Hannan, RE Widdop |
Current Hypertension Reports | 2004 |
Human skin: source of and target organ for angiotensin II
UM Steckelings, T Wollschlager, J Peters, BM Henz, B Hermes, M Artuc |
Experimental Dermatology | 2004 |
Are angiotensin receptor blockers neuroprotective?
C Thöne-Reineke, M Zimmermann, C Neumann, M Krikov, J Li, N Gerova, T Unger |
Current Hypertension Reports | 2004 |
Challenges in improving prognosis and therapy: The Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial Programme
M Zimmermann, T Unger |
Expert Opinion on Pharmacotherapy | 2004 |
Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure
YH Liu, XP Yang, EG Shesely, SS Sankey, OA Carretero |
Journal of the American College of Cardiology | 2004 |
Vasoactive Peptides, their Receptors and Drug Development
H Kusserow, T Unger |
Pharmacology and Toxicology | 2004 |
Combined Treatment with an AT1 Receptor Blocker and Angiotensin Converting Enzyme Inhibitor Has an Additive Effect on Inhibiting Neointima Formation via Improvement of Nitric Oxide Production and Suppression of Oxidative Stress
S YAGI, T MORITA, S KATAYAMA |
Hypertension Research | 2004 |
Angiogenic growth factors and hypertension
DC Sane, L Anton, KB Brosnihan |
Angiogenesis | 2004 |
Impact of Angiotensin II Type 2 Receptor Blockade on Experimental Radiation Nephropathy
JE Moulder, BL Fish, EP Cohen |
Radiation Research | 2004 |
AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction
M Azadpour, GA Lamas |
Expert Review of Cardiovascular Therapy | 2004 |
Apoptosis after reperfused myocardial infarction: Role of angiotensin II
BI Jugdutt |
Experimental and clinical cardiology | 2004 |
Hypothesis: a new role for the Renin-Angiotensin system in ureteric bud branching
IV Yosypiv |
Organogenesis | 2004 |
Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation
K Hama, H Ohnishi, H Yasuda, N Ueda, H Mashima, Y Satoh, K Hanatsuka, H Kita, A Ohashi, K Tamada, K Sugano |
Biochemical and Biophysical Research Communications | 2004 |
Inflammatory mediators and growth factors in obstructive renal injury
R Misseri, RC Rink, DR Meldrum, KK Meldrum |
Journal of Surgical Research | 2004 |
Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas
PF Wong, SS Lee, WT Cheung |
Regulatory Peptides | 2004 |
Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression
WR Schelman, R Andres, P Ferguson, B Orr, E Kang, JA Weyhenmeyer |
Molecular Brain Research | 2004 |
Development of AT1 and AT2 receptors in the ovine fetal brain
F Hu, P Morrissey, J Yao, Z Xu |
Developmental Brain Research | 2004 |
Los inhibidores de la enzima de conversión tienen ventajas sobre los antagonistas de los receptores de angiotensina II
JM de la Ossa |
Hipertensión y Riesgo Vascular | 2004 |
Effects of Losartan and Chlorthalidone on Blood Pressure and Renal Vascular Resistance Index in Non-Diabetic Patients with Essential Hypertension and Normal Renal Function:
D Caruso, M D'Avino, C Acampora, L Romano, N Bevilacqua, G Caruso, DD Esposti, C Borghi |
Journal of Cardiovascular Pharmacology | 2004 |
Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP
S Nouet, N Amzallag, JM Li, S Louis, I Seitz, TX Cui, AM Alleaume, MD Benedetto, C Boden, M Masson, AD Strosberg, M Horiuchi, PO Couraud, C Nahmias |
The Journal of biological chemistry | 2004 |
Immunohistochemical and mRNA Localization of the Angiotensin II Receptor Subtype 2 (AT2) in Follicular Granulosa Cells of the Rat Ovary
N Obermüller, M Gentili, S Gauer, N Gretz, M Weigel, H Geiger, N Gassler |
Journal of Histochemistry & Cytochemistry | 2004 |
The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (−1332 G/A) in a cohort of 509 families with premature coronary artery disease
K Alfakih, RA Lawrance, A Maqbool, K Walters, SG Ball, AJ Balmforth, AS Hall |
European Heart Journal | 2004 |
Angiotensin Vol. II
T Unger, BA Schölkens |
2004 | |
Angiotensin Vol. I
T Unger, BA Schölkens |
2004 | |
Calcium Channel Pharmacology
SI McDonough |
2004 | |
Système rénine angiotensine et angiogenèse post-ischémique
JS Silvestre, et Bernard I. Lévy |
Bulletin de l'Académie nationale de médecine | 2004 |
AT 2 Receptors Attenuate AT 1 Receptor-Induced Phospholipase D Activation in Vascular Smooth Muscle Cells
BT Andresen, GG Romero, EK Jackson |
The Journal of pharmacology and experimental therapeutics | 2004 |
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model
N Hashimoto, Y Maeshima, M Satoh, M Odawara, H Sugiyama, N Kashihara, H Matsubara, Y Yamasaki, H Makino |
American journal of physiology. Renal physiology | 2003 |
Angiotensin AT2receptors: cardiovascular hope or hype?
RE Widdop, ES Jones, RE Hannan, TA Gaspari |
British Journal of Pharmacology | 2003 |
RAS and connective tissue in the heart
Y Sun, KT Weber |
The International Journal of Biochemistry & Cell Biology | 2003 |
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders
GH Goossens, EE Blaak, MA van Baak |
Obesity Reviews | 2003 |
Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?
JP Higgins |
Southern Medical Journal | 2003 |
Angiotensin II AT2 receptor subtype
M Volpe, B Musumeci, PD Paolis, C Savoia, A Morganti |
Journal of Hypertension | 2003 |
Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin
S Sarlos, B Rizkalla, CJ Moravski, Z Cao, ME Cooper, JL Wilkinson-Berka |
The American Journal of Pathology | 2003 |
Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction
AM Salam |
Expert Opinion on Investigational Drugs | 2003 |
Effects of KD3-671, an Angiotensin II Type 1 Receptor Antagonist, on Anti-Thy-1 Nephritis in Rats
T Nagamatsu, T Oka, T Nagao, Y Suzuki |
Biological & Pharmaceutical Bulletin | 2003 |
Effects of Angiotensin II on Nitric Oxide Generation in Proliferating and Quiescent Rat Coronary Microvascular Endothelial Cells
U BAYRAKTUTAN, S ÜLKER |
Hypertension Research | 2003 |
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats
C Pees, T Unger, P Gohlke |
The International Journal of Biochemistry & Cell Biology | 2003 |
Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium
D Jacques, NA Malak, S Sader, C Perreault |
Canadian Journal of Physiology and Pharmacology | 2003 |
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells
Y Zhao, T Biermann, C Luther, T Unger, J Culman, P Gohlke |
Journal of Neurochemistry | 2003 |
Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells
U Bayraktutan |
Journal of Hypertension | 2003 |
AT1 and AT2 receptors in human glomerular endothelial cells at different passages
B Cresci, S Giannini, L Pala, C Mavilia, C Manuelli, P Cappugi, E Magg, CM Rotella |
Microvascular Research | 2003 |
Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat
D Chatelain, V Montel, A Dickes-Coopman, A Chatelain, S Deloof |
Regulatory Peptides | 2003 |
Characterization of angiotensin II–receptor subtypes in podocytes
L Wang, PJ Flannery, RF Spurney |
Journal of Laboratory and Clinical Medicine | 2003 |
The regulation of HGF and TGF-β by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury
J Araya, T Tsuruma, K Hirata, A Yagihashi, M Meguro, M Kawakami, Y Yanai, N Watanabe |
Transplantation Proceedings | 2003 |
Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts
D Kumar, V Menon, WR Ford, AS Clanachan, BI Jugdutt |
Journal of cardiovascular pharmacology and therapeutics | 2003 |
Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression
B Gingras, G Rodier, E Giasson, P Coulombe, C Chassagne, S Meloche |
Oncogene | 2003 |
Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice
X Yan, RL Price, M Nakayama, K Ito, AJ Schuldt, WJ Manning, A Sanbe, TK Borg, J Robbins, BH Lorell |
American journal of physiology. Heart and circulatory physiology | 2003 |
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage
V Grishko, V Pastukh, V Solodushko, M Gillespie, J Azuma, S Schaffer |
American journal of physiology. Heart and circulatory physiology | 2003 |
A role for angiotensin II AT 1 receptors in ureteric bud cell branching
IV Iosipiv, M Schroeder |
American journal of physiology. Renal physiology | 2003 |
Hypoxia and high glucose upregulate AT 1 receptor expression and potentiate ANG II-induced proliferation in VSM cells
CP Sodhi, YS Kanwar, A Sahai |
American journal of physiology. Heart and circulatory physiology | 2003 |
Angiotensin II mediates LDL-induced superoxide generation in mesangial cells
SY Park, CY Song, BC Kim, HK Hong, HS Lee |
American journal of physiology. Renal physiology | 2003 |
An AT1-Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor Protect Against Hypoxia-Induced Apoptosis in Human Aortic Endothelial Cells Through Upregulation of Endothelial Cell Nitric Oxide Synthase Activity:
N Matsumoto, H Manabe, J Ochiai, N Fujita, T Takagi, M Uemura, Y Naito, N Yoshida, S Oka, T Yoshikawa |
Shock | 2003 |
Differential regulation of in vivo angiogenesis by angiotensin II receptors
T Walther, A Menrad, HD Orzechowski, G Siemeister, M Paul, M Schirner |
The FASEB Journal | 2003 |
Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis
S Kurisu, R Ozono, T Oshima, M Kambe, T Ishida, H Sugino, H Matsuura, K Chayama, Y Teranishi, O Iba, K Amano, H Matsubara |
Hypertension | 2003 |
Cardiac Remodeling and Failure
PK Singal, IM Dixon, LA Kirshenbaum, NS Dhalla |
2003 | |
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT 1 and AT 2 Receptors
B Rizkalla, JM Forbes, ME Cooper, Z Cao |
Journal of the American Society of Nephrology : JASN | 2003 |
Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury
Z Cao, F Bonnet, R Candido, SP Nesteroff, WC Burns, H Kawachi, F Shimizu, RM Carey, MD Gasparo, ME Cooper |
Journal of the American Society of Nephrology : JASN | 2002 |
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis1
UO Wenzel, F Thaiss, U Helmchen, RA Stahl, G Wolf |
Kidney International | 2002 |
Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb
JS Silvestre, R Tamarat, T Senbonmatsu, T Icchiki, T Ebrahimian, M Iglarz, S Besnard, M Duriez, T Inagami, BI Lévy |
Circulation research | 2002 |
Vasoconstriction is determined by interstitial rather than circulating angiotensin II
MP Schuijt, R Vries, PR Saxena, MA Schalekamp, AH Danser |
British Journal of Pharmacology | 2002 |
Expression and Role of Angiotensin II Type 2 Receptor in the Kidney and Mesangial Cells of Spontaneously Hypertensive Rats
M GOTO, M MUKOYAMA, A SUGAWARA, T SUGANAMI, M KASAHARA, K YAHATA, H MAKINO, S SUGA, I TANAKA, K NAKAO |
Hypertension Research | 2002 |
Angiotensin II type 2 (AT2) receptor signal and cardiovascular action
H MATSUBARA |
Folia Pharmacologica Japonica | 2002 |
Multiple Interactions Between the Renin-Angiotensin and the Kallikrein-Kinin Systems: Role of ACE Inhibition and AT1 Receptor Blockade
C Tschöpe, HP Schultheiss, T Walther |
Journal of Cardiovascular Pharmacology | 2002 |
Contrasting Effects of Angiotensin Type 1 and 2 Receptors on Nitric Oxide Release under Pressure
S HARADA, T NAKATA, A OGUNI, H KIDO, T HATTA, R FUKUYAMA, S FUSHIKI, S SASAKI, K TAKEDA |
Hypertension Research | 2002 |
Chronic Hypotensive Effects of Losartan Are Not Dependent on the Actions of Angiotensin II at AT 2 Receptors
JP Collister, SL Soucheray, JW Osborn |
Journal of Cardiovascular Pharmacology | 2002 |
Inhibition of Vascular Smooth Muscle Cell Growth by Angiotensin Type 2 Receptor Stimulation for In Vitro Organ Culture Model
L Brogelli, A Parenti, F Ledda |
Journal of Cardiovascular Pharmacology | 2002 |
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts
PD Paolis, A Porcellini, C Savoia, A Lombardi, B Gigante, G Frati, S Rubattu, B Musumeci, M Volpe |
Journal of Hypertension | 2002 |
Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma
H Takeda, Y Katagata, S Kondo |
British Journal of Dermatology | 2002 |
Local Cardiac Renin–Angiotensin System: Hypertension and Cardiac Failure
J Varagic, ED Frohlich |
Journal of Molecular and Cellular Cardiology | 2002 |
Multiple Interactions Between the Renin-Angiotensin and the Kallikrein-Kinin Systems: Role of ACE Inhibition and AT1 Receptor Blockade:
C Tschöpe, HP Schultheiss, T Walther |
Journal of Cardiovascular Pharmacology | 2002 |
The role of the renin-angiotensin system in the development of cardiovascular disease
T Unger |
The American Journal of Cardiology | 2002 |
Identification of the region of AT2 receptor needed for inhibition of the AT1 receptor-mediated inositol 1,4,5-triphosphate generation
V Kumar, D Knowle, N Gavini, L Pulakat |
FEBS Letters | 2002 |
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways
R Tamarat, JS Silvestre, M Durie, BI Levy |
Laboratory Investigation | 2002 |
Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies
SM Herrmann, V Nicaud, K Schmidt-Petersen, J Pfeifer, J Erdmann, T McDonagh, HJ Dargie, M Paul, V Regitz-Zagrosek |
European Journal of Heart Failure | 2002 |
Angiotensin II's Antiproliferative Effects Mediated Through AT2-Receptors Depend On Down-Regulation of SM-20
G Wolf, S Harendza, R Schroeder, U Wenzel, G Zahner, U Butzmann, RS Freeman, RA Stahl |
Laboratory Investigation | 2002 |
The Role of the Renin-Angiotensin System in Cholesterol and Puromycin Mediated Renal Injury
S Ghosh, D Sica, AC Schoolwerth, I Fakhry, TW Gehr, RJ Quigg, M Haas |
The American Journal of the Medical Sciences | 2002 |
Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT 2 Receptor Signaling Pathway in NG108-15 Cells
L Gendron, JF Oligny, MD Payet, N Gallo-Payet |
The Journal of biological chemistry | 2002 |
Angiotensin II receptor (type 1 and 2) expression peaks when placental growth is maximal in sheep
I Koukoulas, T Mustafa, R Douglas-Denton, EM Wintour |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2002 |
AT 1 and AT 2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts
Y Xu, D Kumar, JR Dyck, WR Ford, AS Clanachan, GD Lopaschuk, BI Jugdutt |
American journal of physiology. Heart and circulatory physiology | 2002 |
Angiotensin receptor subtype AT 1 mediates alveolar epithelial cell apoptosis in response to ANG II
M Papp, X Li, J Zhuang, R Wang, BD Uhal |
American journal of physiology. Lung cellular and molecular physiology | 2002 |
‘The road not taken’: role of angiotensin II type 2 receptor in pathophysiology
G Wolf |
Nephrology Dialysis Transplantation | 2002 |
Obstructive Uropathy: An Important Cause of Chronic Renal Failure in Children
KS Roth, HP Koo, SE Spottswood, JC Chan |
Clinical Pediatrics | 2002 |
Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT2- receptors
S Phoon, LG Howes |
Journal of Renin-Angiotensin-Aldosterone System | 2002 |
TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats:
J Araya, T Tsuruma, K Hirata, A Yagihashi, N Watanabe |
Transplantation | 2002 |
Effect of Angiotensin II Type 1 Receptor Blockade on Cardiac Remodeling in Angiotensin II Type 2 Receptor Null Mice
L Wu, M Iwai, H Nakagami, R Chen, J Suzuki, M Akishita, M de Gasparo, M Horiuchi |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
The New Angiotherapy
TP Fan, EC Kohn |
2002 | |
Role of AT 2 Receptors in the Cardioprotective Effect of AT 1 Antagonists in Mice
J Xu, OA Carretero, YH Liu, EG Shesely, F Yang, A Kapke, XP Yang |
Hypertension | 2002 |
Endothelial Nitric Oxide Synthase Lies Downstream From Angiotensin II–Induced Angiogenesis in Ischemic Hindlimb
R Tamarat, JS Silvestre, N Kubis, J Benessiano, M Duriez, M deGasparo, D Henrion, BI Levy |
Hypertension | 2002 |
Aldosterone Breakthrough During Angiotensin II Receptor Antagonist Therapy in Stroke-Prone Spontaneously Hypertensive Rats
M Naruse, A Tanabe, A Sato, S Takagi, K Tsuchiya, T Imaki, K Takano |
Hypertension | 2002 |
Identification of a Zinc Finger Homoeodomain Enhancer Protein After AT 2 Receptor Stimulation by Differential mRNA Display
M Stoll, AW Hahn, U Jonas, Y Zhao, B Schieffer, JW Fischer, T Unger |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Angiotensin AT2 Receptor Ligands: Do They Have Potential as Future Treatments for Neurological Disease?
P Rosenstiel, S Gallinat, A Arlt, T Unger, J Sievers, R Lucius |
CNS Drugs | 2002 |
Angiotensin II Receptor Antagonists in Chronic Heart Failure: Where Do They Fit?
AR Houghton |
Drugs | 2002 |
Implications physiopathologiques et cliniques des r??cepteurs AT1/AT2 de l??angiotensine II dans l??insuffisance cardiaque, coronaire et r??nale:
S Sandmann, T Unger |
Drugs | 2002 |
Les r??cepteurs AT1 et AT2 de l??angiotensine II: L??essentiel
M de Gasparo |
Drugs | 2002 |
ACE Inhibitors versus AT 1 Receptor Antagonists in Patients with Chronic Renal Disease
KF Hilgers, JF Mann |
Journal of the American Society of Nephrology : JASN | 2002 |
Involvement of alpha3 integrin/tetraspanin complexes in the angiogenic response induced by angiotensin II
C Domínguez-Jiménez, M Yáñez-Mó, A Carreira, R Tejedor, R González-Amaro, V Alvarez, F Sánchez-Madrid |
The FASEB Journal | 2001 |
Two Distinct Mechanisms of Angiotensin II-Induced Negative Regulation of the Mitogen-Activated Protein Kinases in Cultured Cardiac Myocytes
Y HIROI, J HIROI, S KUDOH, Y YAZAKI, R NAGAI, I KOMURO |
Hypertension Research | 2001 |
Protection against ischemia: a physiological function of the renin-angiotensin system
J Achard |
Biochemical Pharmacology | 2001 |
Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3− symporter in the rat heart after myocardial infarction
S Sandmann, M Yu, E Kaschina, A Blume, E Bouzinova, C Aalkjaer, T Unger |
Journal of the American College of Cardiology | 2001 |
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction - effects of AT1and AT2receptor antagonists and ACE inhibitor
S Sandmann, M Yu, T Unger |
British Journal of Pharmacology | 2001 |
Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats
N Kobayashi |
Atherosclerosis | 2001 |
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease
BV Khan, S Navalkar, QA Khan, ST Rahman, S Parthasarathy |
Journal of the American College of Cardiology | 2001 |
Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion
F Bonnet, ME Cooper, RM Carey, D Casley, Z Cao |
Journal of Hypertension | 2001 |
Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy?
EL Schiffrin |
Current Opinion in Nephrology and Hypertension | 2001 |
Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor Expression
H Takeda, S Kondo |
The American Journal of Pathology | 2001 |
Interactions of Ligands at Angiotensin II-Receptors and Imidazoline Receptors
U Wethmar, W Raasch, A Dendorfer, P Dominiak |
The Japanese Journal of Pharmacology | 2001 |
Role Of Angiotensin Type 2 Receptors In Human Forearm Vascular Responses Of Normal Volunteers
S Phoon, LG Howes |
Clinical and Experimental Pharmacology and Physiology | 2001 |
Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma
H Takeda, S Kondo |
British Journal of Dermatology | 2001 |
Coronary Capillary Remodeling in Non-Insulin-Dependent Diabetic Rats: Amelioration by Inhibition of Angiotensin Converting Enzyme and Its Potential Clinical Implications
T SUGAWARA, S FUJII, AK Tarikuz, D GOTO, T KANEKO, T FURUMOTO, H TOGASHI, M YOSHIOKA, T KOYAMA, A KITABATAKE |
Hypertension Research | 2001 |
Angiotensin II type 2 receptors: signalling and pathophysiological role
A Blume, E Kaschina, T Unger |
Current Opinion in Nephrology and Hypertension | 2001 |
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
E Rivera, O Arrieta, P Guevara, A Duarte-Rojo, J Sotelo |
British Journal of Cancer | 2001 |
Role of the angiotensin II receptor blocker valsartan in heart failure
RL Webb, M Gasparo |
Experimental and clinical cardiology | 2001 |
Effect of Angiotensin II Type 2 Receptor on Tyrosine Kinase Pyk2 and c-Jun NH2-Terminal Kinase via SHP-1 Tyrosine Phosphatase Activity: Evidence from Vascular-Targeted Transgenic Mice of AT2 Receptor
H Matsubara, Y Shibasaki, M Okigaki, Y Mori, H Masaki, A Kosaki, Y Tsutsumi, Y Uchiyama, S Fujiyama, A Nose, O Iba, E Tateishi, T Hasegawa, M Horiuchi, C Nahmias, T Iwasaka |
Biochemical and Biophysical Research Communications | 2001 |
Role of Asp297 of the AT2 receptor in high-affinity binding to different peptide ligands
D Knowle, J Kurfis, N Gavini, L Pulakat |
Peptides | 2001 |
Differential Activation of the STAT Pathway by Angiotensin II via Angiotensin Type 1 and Type 2 Receptors in Cultured Human Fetal Mesangial Cells
FA Seebach, T Welte, XY Fu, LH Block, M Kashgarian |
Experimental and Molecular Pathology | 2001 |
Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs
Y Oikawa, K Maehara, T Saito, K Tamagawa, Y Maruyama |
Journal of the American College of Cardiology | 2001 |
Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system
M Brede, L Hein |
Regulatory Peptides | 2001 |
Angiotensin and its AT2 receptor: new insights into an old system
M Stoll, T Unger |
Regulatory Peptides | 2001 |
Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension
JF Peng, MI Phillips |
Regulatory Peptides | 2001 |
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu |
Heart Physiology and Pathophysiology | 2001 |
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist
Y Fujimoto, T Sasaki, A Tsuchida, K Chayama |
FEBS Letters | 2001 |
Angiotensin II type 1 receptor blockers
M Burnier |
Circulation | 2001 |
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
H Gavras, HR Brunner |
American journal of physiology. Heart and circulatory physiology | 2001 |
Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats
AF Moore, NT Heiderstadt, E Huang, NL Howell, ZQ Wang, HM Siragy, RM Carey |
Hypertension | 2001 |
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase
Y Shibasaki, H Matsubara, Y Nozawa, Y Mori, H Masaki, A Kosaki, Y Tsutsumi, Y Uchiyama, S Fujiyama, A Nose, O Iba, E Tateishi, T Hasegawa, M Horiuchi, C Nahmias, T Iwasaka |
Hypertension | 2001 |
Angiotensin II Binding Sites in the Heart of Scyliorhinus canicula: An Autoradiographic Study
MC Cerra, ML Tierney, Y Takei, N Hazon, B Tota |
General and Comparative Endocrinology | 2001 |
Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats
T Omura, M Yoshiyama, F Ishikura, H Kobayashi, K Takeuchi, S Beppu, J Yoshikawa |
Journal of Molecular and Cellular Cardiology | 2001 |
Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats
M Yoshiyama, T Omura, K Takeuchi, S Kim, K Shimada, H Yamagishi, M Teragaki, K Akioka, H Iwao, J Yoshikawa |
Journal of Molecular and Cellular Cardiology | 2001 |
AT RECEPTOR INHIBITION AFFECTS THE NORADRENALINE SENSITIVITY IN ISOLATED PORTAL VEIN OF NORMOTENSIVE RAT
JY Datté, JY Datté, P Gohlke, C Pees, A Ziegler |
Clinical and Experimental Hypertension | 2001 |
Expanded role for ARBs in cardiovascular and renal disease?: Recent observations have far-reaching implications
TM Ramahi |
Postgraduate Medicine | 2001 |
Addressing Those Two That Go Together: The Angiotensin II Receptors and their Role in Blood-flow Regulation
R Fogari, MD Gasparo |
Blood Pressure | 2001 |
Small Artery Remodeling in Hypertension: Can It Be Corrected?
MA Moore, EL Schiffrin |
The American Journal of the Medical Sciences | 2001 |
AT 2 receptor-mediated vasodilation in the heart: effect of myocardial infarction
MP Schuijt, M Basdew, R Veghel, R Vries, PR Saxena, RG Schoemaker, AH Danser |
American journal of physiology. Heart and circulatory physiology | 2001 |
Angiotensin II AT 2 receptors inhibit growth responses in proximal tubule cells
J Zimpelmann, KD Burns |
American journal of physiology. Renal physiology | 2001 |
Comparative Effects of ACE Inhibitors and an Angiotensin Receptor Blocker on Atherosclerosis and Vascular Function
Y Sun, B Zhu, AE Browne, S Pulukurthy, TM Chou, K Sudhir, SA Glantz, PC Deedwania, K Chatterjee, WW Parmley |
Journal of cardiovascular pharmacology and therapeutics | 2001 |
ANG II potentiates mitogenic effect of norepinephrine in vascular muscle cells: role of FGF-2
A Parenti, L Brogelli, S Donnini, M Ziche, F Ledda |
American journal of physiology. Heart and circulatory physiology | 2001 |
Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion
R Schulz, G Heusch |
Journal of Renin-Angiotensin-Aldosterone System | 2001 |
Review: AT1-receptors in the central nervous system
AM Allen, ME Giles, JH Lee, BJ Oldfield, FA Mendelsohn, MJ McKinley |
Journal of Renin-Angiotensin-Aldosterone System | 2001 |
Vascular Hypertrophy and Increased P70S6 Kinase in Mice Lacking the Angiotensin II AT 2 Receptor
M Brede, K Hadamek, L Meinel, F Wiesmann, J Peters, S Engelhardt, A Simm, A Haase, MJ Lohse, L Hein |
Circulation | 2001 |
Angiotensin AT 1 and AT 2 Receptors Differentially Regulate Angiopoietin-2 and Vascular Endothelial Growth Factor Expression and Angiogenesis by Modulating Heparin Binding–Epidermal Growth Factor (EGF)–Mediated EGF Receptor Transactivation
S Fujiyama, H Matsubara, Y Nozawa, K Maruyama, Y Mori, Y Tsutsumi, H Masaki, Y Uchiyama, Y Koyama, A Nose, O Iba, E Tateishi, N Ogata, N Jyo, S Higashiyama, T Iwasaka |
Circulation research | 2001 |
Apoptosis Is Not Increased in Myocardium Overexpressing Type 2 Angiotensin II Receptor in Transgenic Mice
H Sugino, R Ozono, S Kurisu, H Matsuura, M Ishida, T Oshima, M Kambe, Y Teranishi, H Masaki, H Matsubara |
Hypertension | 2001 |
Coronary Hemodynamic and Ventricular Responses to Angiotensin Type 1 Receptor Inhibition in SHR: Interaction With Angiotensin Type 2 Receptors
J Varagic, D Susic, ED Frohlich |
Hypertension | 2001 |
Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes
LH Opie, MN Sack |
Circulation research | 2001 |
Workshop: Hypertension and Cardiovascular Risk Factors: Role of the Angiotensin II–Nitric Oxide Interaction
L Raij |
Hypertension | 2001 |
Angiotensin Type 1 Receptor Antagonism and ACE Inhibition Produce Similar Renoprotection in Nω -Nitro- l >-Arginine Methyl Ester/Spontaneously Hypertensive Rats
Y Nakamura, H Ono, X Zhou, ED Frohlich |
Hypertension | 2001 |
Blockade of Angiotensin Receptor Subtypes in Arcuate Uterine Artery of Pregnant and Postpartum Rats
J St-Louis, B Sicotte, S Bédard, M Brochu |
Hypertension | 2001 |
Activation of Angiotensin II Subtype 2 Receptor Induces Catecholamine Release in an Extracellular Ca2+-Dependent Manner through a Decrease of Cyclic Guanosine 3′,5′-Monophosphate Production in Cultured Porcine Adrenal Medullary Chromaffin Cells*
K Takekoshi, K Ishii, Y Kawakami, K Isobe, T Nakai |
Endocrinology | 2001 |
Klinische Diabetologie
BO Böhm, KD Palitzsch, C Rosak, GA Spinas |
2001 | |
Chimeric AT 1 /AT 2 Receptors Reveal Functional Similarities Despite Key Amino Acid Dissimilarities in the Domains Mediating Agonist-Dependent Activation
J Hines, SJ Fluharty, DK Yee |
Biochemistry | 2001 |
Evolution and Pathophysiology of Chronic Systolic Heart Failure
BE Bleske |
Pharmacotherapy | 2000 |
The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice
TE Hunley, M Tamura, BJ Stoneking, H Nishimura, T Ichiki, T Inagami, V Kon |
Kidney International | 2000 |
Differential role of angiotensin II receptor subtypes on endothelial superoxide formation
HY Sohn, U Raff, A Hoffmann, T Gloe, K Heermeier, J Galle, U Pohl |
British Journal of Pharmacology | 2000 |
Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats
K Amann, P Gassmann, M Buzello, SR Orth, J Tornig, ML Gross, A Magener, G Mall, E Ritz |
Kidney International | 2000 |
Angiotensin I-Converting Enzyme
D Crisan, J Carr |
The Journal of Molecular Diagnostics | 2000 |
Effects of antihypertensive therapy on hypertensive vascular disease
JB Park, EL Schiffrin |
Current Hypertension Reports | 2000 |
The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure
WL Lombardi, EM Gilbert |
Current Cardiology Reports | 2000 |
Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis
Z Cao, DJ Kelly, A Cox, D Casley, JM Forbes, P Martinello, R Dean, RE Gilbert, ME Cooper |
Kidney International | 2000 |
Apoptosis inhibition of cellular proliferation by II: possible implication and perspectives
I Mucsi, L Rosivall, B Antus |
Acta Physiologica Hungarica | 2000 |
Expression of Angiotensin AT1 and AT2 Receptors in Adult Rat Cardiomyocytes after Myocardial Infarction
S Busche, S Gallinat, RM Bohle, A Reinecke, J Seebeck, F Franke, L Fink, M Zhu, C Sumners, T Unger |
The American Journal of Pathology | 2000 |
Angiotensin II receptor antagonists
M Burnier, HR Brunner |
The Lancet | 2000 |
Effect of cortisol on fetal ovine vascular angiotensin II receptors and contractility
BD Hegarty, JH Burrell, KJ Gibson, JR McMullen, ER Lumbers |
European Journal of Pharmacology | 2000 |
Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats
M Sugano, K Tsuchida, S Sawada, N Makino |
Journal of Hypertension | 2000 |
Analysis of the genetic basis of the endothelium-dependent impaired vasorelaxation in the stroke-prone spontaneously hypertensive rat
S Rubattu, R Giliberti, R Russo, B Gigante, U Ganten, M Volpe |
Journal of Hypertension | 2000 |
Lack of association between polymorphisms of angiotensin II receptor genes and response to short-term angiotensin II infusion
C Delles, J Erdmann, J Jacobi, E Fleck, V Regitz-Zagrosek, RE Schmieder |
Journal of Hypertension | 2000 |
Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed rats
M Tamura, T Takagi, EF Howard, EJ Landon, A Steimle, M Tanner, PR Myers |
Journal of Hypertension | 2000 |
Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis
S Miura, SS Karnik |
The EMBO Journal | 2000 |
Angiotensin-II Subtype 2 Receptor Agonist (CGP-42112) Inhibits Catecholamine Biosynthesis in Cultured Porcine Adrenal Medullary Chromaffin Cells
K Takekoshi, K Ishii, K Isobe, T Nanmoku, Y Kawakami, T Nakai |
Biochemical and Biophysical Research Communications | 2000 |
The cardiac renin–angiotensin system: novel signaling mechanisms related to cardiac growth and function
DE Dostal |
Regulatory Peptides | 2000 |
Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family
D Knowle, S Ahmed, L Pulakat |
Regulatory Peptides | 2000 |
Neurohormonal modulation in cardiovascular disease
T Unger |
American Heart Journal | 2000 |
Angiotensin AT2 receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells
U Stroth, A Blume, K Mielke, T Unger |
Molecular Brain Research | 2000 |
Enhancing cardiac protection after myocardial infarction: Rationale for newer clinical trials of angiotensin receptor blockers
MA Pfeffer |
American Heart Journal | 2000 |
Angiotensin II Subtype-2 receptor influences kininogenase activity
HM Siragy |
American Journal of Kidney Diseases | 2000 |
Author’s reply:
H Matsubara |
American Journal of Kidney Diseases | 2000 |
Inflammation influences vascular remodeling through AT2 receptor expression and signaling
M Akishita, M Horiuchi, H Yamada, L Zhang, G Shirakami, K Tamura, Y Ouchi, VJ Dzau |
Physiological genomics | 2000 |
Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension
C Chassagne, S Eddahibi, C Adamy, D Rideau, F Marotte, JL Dubois-Randé, S Adnot, JL Samuel, E Teiger |
American journal of respiratory cell and molecular biology | 2000 |
Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor
RM Carey, ZQ Wang, HM Siragy |
Current Hypertension Reports | 2000 |
Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function
RM Carey, ZQ Wang, HM Siragy |
Hypertension | 2000 |
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice
M Akishita, M Iwai, L Wu, L Zhang, Y Ouchi, VJ Dzau, M Horiuchi |
Circulation | 2000 |
Angiotensin II and its receptors in the diabetic kidney
KD Burns |
American Journal of Kidney Diseases | 2000 |
Molecular and Genetic Aspects of Preeclampsia: State of the Art
G Tálosi, E Endreffy, S Túri, I Németh |
Molecular Genetics and Metabolism | 2000 |
Effects of Angiotensin II AT1-Receptor Blockade on Coronary Dynamics, Function, and Structure in Postischemic Heart Failure in Rats:
M Gervais, P Fornes, C Richer, D Nisato, JF Giudicelli |
Journal of Cardiovascular Pharmacology | 2000 |
Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKCε Proteins and cGMP
BI Jugdutt, Y Xu, M Balghith, R Moudgil, V Menon |
Journal of cardiovascular pharmacology and therapeutics | 2000 |
The angiotensin II type 2 receptor: an enigma with multiple variations
S Gallinat, S Busche, MK Raizada, C Sumners |
American journal of physiology. Endocrinology and metabolism | 2000 |
Recruitable ACE and tissue repair in the infarcted heart
KT Weber, Y Sun |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes
C Wei, MG Cardarelli, SW Downing, JS McLaughlin |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
ME El-Sabban, KA Hassan, AE Birbari, KM Bitar, AB Bikhazi |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Measurement of the Renin-Angiotensin System in Heart Failure
SD Kim |
Biological research for nursing | 2000 |
Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart
R Ozono, T Matsumoto, T Shingu, T Oshima, Y Teranishi, M Kambe, H Matsuura, G Kajiyama, ZQ Wang, AF Moore, RM Carey |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2000 |
Angiotensinogen and AT 1 antisense inhibition of osteopontin translation in rat proximal tubular cells
SD Ricardo, DF Franzoni, CD Roesener, JM Crisman, JR Diamond |
American journal of physiology. Renal physiology | 2000 |
Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injury
J Lemay, P Hamet, D deBlois |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Angiotensin receptor blocker selectivity at the AT 1 - and AT 2 -receptors: conceptual and clinical effects
T Unger, S Sandmann |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
Oxidized LDL Upregulates Angiotensin II Type 1 Receptor Expression in Cultured Human Coronary Artery Endothelial Cells: The Potential Role of Transcription Factor NF-κB
D Li, T Saldeen, F Romeo, JL Mehta |
Circulation | 2000 |
Angiotensin II Receptor Subtypes in the Skeletal Muscle Vasculature of Patients With Severe Congestive Heart Failure
SL Malendowicz, PV Ennezat, M Testa, L Murray, EH Sonnenblick, T Evans, TH LeJemtel |
Circulation | 2000 |
Interferon-γ Induces AT 2 Receptor Expression in Fibroblasts by Jak/STAT Pathway and Interferon Regulatory Factor-1
M Horiuchi, W Hayashida, M Akishita, S Yamada, JY Lehtonen, K Tamura, L Daviet, YE Chen, M Hamai, TX Cui, M Iwai, Y Minokoshi |
Circulation research | 2000 |
Proapoptotic and Growth-Inhibitory Role of Angiotensin II Type 2 Receptor in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats In Vivo
BS Tea, SD Sarkissian, RM Touyz, P Hamet, D deBlois |
Hypertension | 2000 |
The Hypertrophied Heart
N Takeda, M Nagano, NS Dhalla |
2000 | |
Tolerability and Antihypertensive Efficacy of Losartan vs Captopril in Patients with Mild to Moderate Hypertension and Impaired Renal Function: A Randomised, Double-Blind, Parallel Study
E Schulz, JN Bech, EB Pedersen, R Zavala, M Ruiz, GA Mller |
Clinical Drug Investigation | 2000 |
ACE inhibitors and AT1 receptor antagonists—beyond the haemodynamic effect
M RuizOrtega, O Lorenzo, M Ruperez, J Egido |
Nephrology Dialysis Transplantation | 2000 |
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
M Akishita, M Ito, JY Lehtonen, L Daviet, VJ Dzau, M Horiuchi |
Journal of Clinical Investigation | 1999 |
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
Y Tsutsumi, H Matsubara, H Masaki, H Kurihara, S Murasawa, S Takai, M Miyazaki, Y Nozawa, R Ozono, K Nakagawa, T Miwa, N Kawada, Y Mori, Y Shibasaki, Y Tanaka, S Fujiyama, Y Koyama, A Fujiyama, H Takahashi, T Iwasaka |
Journal of Clinical Investigation | 1999 |
The Renin-Angiotensin System and Its Receptors
U Stroth, T Unger |
Journal of Cardiovascular Pharmacology | 1999 |
Mechanism of action of angiotensin-receptor blocking agents
HM Siragy, M Bedigian |
Current Hypertension Reports | 1999 |
Effects of a novel angiotensin AT1 receptor antagonist, HR720, on rats with myocardial infarction
QG Xia, O Chung, H Spitznagel, S Sandmann, S Illner, B Rossius, G Jähnichen, A Reinecke, P Gohlke, T Unger |
European Journal of Pharmacology | 1999 |
Björn Fokow Award Lecture The angiotensin type 2 receptor
T Unger |
Journal of Hypertension | 1999 |
Novel actions of angiotensin II via its renal type-2 (AT2) receptor
RM Carey, ZQ Wang, HM Siragy |
Current Hypertension Reports | 1999 |
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis
EA Kalkman, P Haren, PR Saxena, RG Schoemaker |
European Journal of Pharmacology | 1999 |
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe |
Journal of Hypertension | 1999 |
No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats
MP Schuijt, R Vries, PR Saxena, AH Danser |
Journal of Hypertension | 1999 |
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition
S Miura, SS Karnik |
Journal of Hypertension | 1999 |
Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
WH Birkenhäger, PW de Leeuw |
Journal of Hypertension | 1999 |
Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts
M Tamura, YJ Chen, EF Howard, M Tanner, EJ Landon, PR Myers |
European Journal of Pharmacology | 1999 |
Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth
M Horiuchi, JY Lehtonen, L Daviet |
Trends in Endocrinology & Metabolism | 1999 |
Selective Potentiation of Angiotensin-Induced Constriction of Skeletal Muscle Resistance Arteries by Chronic Elevations in Dietary Salt Intake
DS Weber, JC Frisbee, JH Lombard |
Microvascular Research | 1999 |
Angiotensin II and extracellular matrix homeostasis
KT Weber, SK Swamynathan, RV Guntaka, Y Sun |
The International Journal of Biochemistry & Cell Biology | 1999 |
The Localization and Expression of the Renin–angiotensin System in the Human Placenta Throughout Pregnancy
AC Cooper, G Robinson, GP Vinson, WT Cheung, FB Pipkin |
Placenta | 1999 |
Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 Receptor
M Akishita, H Yamada, VJ Dzau, M Horiuchi |
Biochemical and Biophysical Research Communications | 1999 |
Vascular Response to Angiotensin II Is Exaggerated through an Upregulation of AT1 Receptor in AT2 Knockout Mice
M Tanaka, S Tsuchida, T Imai, N Fujii, H Miyazaki, T Ichiki, M Naruse, T Inagami |
Biochemical and Biophysical Research Communications | 1999 |
Angiotensin II and nitric oxide: a question of balance
LJ Millatt, EM Abdel-Rahman, HM Siragy |
Regulatory Peptides | 1999 |
The AT2 receptor: fact, fancy and fantasy
M Gasparo, HM Siragy |
Regulatory Peptides | 1999 |
Angiotensin II and connective tissue: homeostasis and reciprocal regulation
KT Weber |
Regulatory Peptides | 1999 |
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells:
PD Paolisa, A Porcellini, B Gigante, R Giliberti, A Lombardi, C Savoia, S Rubattu, M Volpe |
Journal of Hypertension | 1999 |
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
DP Brooks, EH Ohlstein, RR Ruffolo |
American Heart Journal | 1999 |
AT2 receptor stimulation induces generation of ceramides in PC12W cells
S Gallinat, S Busche, S Schütze, M Krönke, T Unger |
FEBS Letters | 1999 |
An A/T-rich cis-element is essential for rat angiotensin II type 1A receptor transcription in vascular smooth muscle cells
KB Beason, CG Acuff, ME Steinhelper, TS Elton |
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | 1999 |
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease
BH Lorell |
The American Journal of Cardiology | 1999 |
Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk
M Horiuchi, W Hayashida, M Akishita, K Tamura, L Daviet, JY Lehtonen, VJ Dzau |
Circulation research | 1999 |
Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development
E Chamoux, L Breault, JG Lehoux, N Gallo-Payet |
The Journal of clinical endocrinology and metabolism | 1999 |
Practical Considerations of the Pharmacology of Angiotensin Receptor Blockers
MM McConnaughey, JS McConnaughey, AJ Ingenito |
The Journal of Clinical Pharmacology | 1999 |
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
DY Li, YC Zhang, MI Philips, T Sawamura, JL Mehta |
Circulation research | 1999 |
Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy
Z Cao, R Dean, L Wu, D Casley, ME Cooper |
Hypertension | 1999 |
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
M Horiuchi, M Akishita, VJ Dzau |
Hypertension | 1999 |
Opposing actions of angiotensins on angiogenesis
RD Machado, RA Santos, SP Andrade |
Life Sciences | 1999 |
Role of the His273 Located in the Sixth Transmembrane Domain of the Angiotensin II Receptor Subtype AT2 in Ligand–Receptor Interaction
CA Turner, S Cooper, L Pulakat |
Biochemical and Biophysical Research Communications | 1999 |
Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory blood pressure monitoring
R Fogari, A Zoppi, L Corradi, L Poletti, E Piazza, A Mugellini, EB Pilun, P Preti |
Current Therapeutic Research | 1999 |
Role of Arg182 in the Second Extracellular Loop of Angiotensin II Receptor AT2 in Ligand Binding
J Kurfis, D Knowle, L Pulakat |
Biochemical and Biophysical Research Communications | 1999 |
Actions of endothelin-1 on cultured rat renomedullary interstitial cells are modulated by nitric oxide
C Maric, G P Aldred, A M Antoine, E Eitle, R G Dean, D A Williams, P J Harris, D Alcorn |
Clinical and experimental pharmacology & physiology | 1999 |
Role of AT 1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice
TJ Bivalacqua, A Dalal, HC Champion, PJ Kadowitz |
American journal of physiology. Endocrinology and metabolism | 1999 |
Renal cellular response to ureteral obstruction: role of maturation and angiotensin II
RL Chevalier, BA Thornhill, JT Wolstenholme |
American journal of physiology. Renal physiology | 1999 |
Effect of AT 2 receptor blockade on the pathogenesis of renal fibrosis
JJ Morrissey, S Klahr |
American journal of physiology. Renal physiology | 1999 |
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT 1 receptor and PKC activation
D Li, B Yang, MI Philips, JL Mehta |
American journal of physiology. Heart and circulatory physiology | 1999 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction
GE Sander, JJ McKinnie, SS Greenberg, TD Giles |
Progress in Cardiovascular Diseases | 1999 |
Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT 1 receptors
NW Morrell, PD Upton, S Kotecha, A Huntley, MH Yacoub, JM Polak, J Wharton |
American journal of physiology. Lung cellular and molecular physiology | 1999 |
Activation of the AT 2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum
F Côté, TH Do, L Laflamme, JM Gallo, N Gallo-Payet |
The Journal of biological chemistry | 1999 |
Activation of the de novo Biosynthesis of Sphingolipids Mediates Angiotensin II Type 2 Receptor-induced Apoptosis
JY Lehtonen, M Horiuchi, L Daviet, M Akishita, VJ Dzau |
The Journal of biological chemistry | 1999 |
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
S Gunasegaram, RS Haworth, DJ Hearse, M Avkiran |
Circulation research | 1999 |
Differential Regulation of Renal Angiotensin Subtype AT 1A and AT 2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension
ZQ Wang, LJ Millatt, NT Heiderstadt, HM Siragy, RA Johns, RM Carey |
Hypertension | 1999 |
Mechanical Stretch and Angiotensin II Differentially Upregulate the Renin-Angiotensin System in Cardiac Myocytes In Vitro
R Malhotra, J Sadoshima, FC Brosius, S Izumo |
Circulation research | 1999 |
Role of AT 2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR
RM Touyz, D Endemann, G He, JS Li, EL Schiffrin |
Hypertension | 1999 |
AT 2 Receptor Stimulation Enhances Antihypertensive Effect of AT 1 Receptor Antagonist in Hypertensive Rats
MN Barber, DB Sampey, RE Widdop |
Hypertension | 1999 |
Angiotensin II Type 2 Receptor Blockade Amplifies the Early Signals of Cardiac Growth Response to Angiotensin II in Hypertrophied Hearts
J Bartunek, EO Weinberg, M Tajima, S Rohrbach, BH Lorell |
Circulation | 1999 |
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
EA Tallant, DI Diz, CM Ferrario |
Hypertension | 1999 |
AT 2 Receptor and Vascular Smooth Muscle Cell Differentiation in Vascular Development
H Yamada, M Akishita, M Ito, K Tamura, L Daviet, JY Lehtonen, VJ Dzau, M Horiuchi |
Hypertension | 1999 |
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo
L Pastore, A Tessitore, S Martinotti, E Toniato, E Alesse, MC Bravi, C Ferri, G Desideri, A Gulino, A Santucci |
Circulation | 1999 |
Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells
M Tamura, Y Wanaka, EJ Landon, T Inagami |
Hypertension | 1999 |
Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells: Involvement of the AT 1 Receptor, Transforming Growth Factor-β, and Tyrosine Phosphorylation
CM Ford, S Li, JG Pickering |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Effects of Candesartan and Cilazapril on Rats With Myocardial Infarction Assessed by Echocardiography
M Yoshiyama, K Takeuchi, T Omura, S Kim, H Yamagishi, I Toda, M Teragaki, K Akioka, H Iwao, J Yoshikawa |
Hypertension | 1999 |
Role of Angiotensin Receptor Blockers in Heart Failure: Not Yet RESOLVD
BH Greenberg |
Circulation | 1999 |
In Vivo Study of AT 1 and AT 2 Angiotensin Receptors in Apoptosis in Rat Blood Vessels
QN Diep, JS Li, EL Schiffrin |
Hypertension | 1999 |
Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis
JY Lehtonen, L Daviet, C Nahmias, M Horiuchi, VJ Dzau |
Molecular Endocrinology | 1999 |
Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain**This work was supported by a grant from the NIH (NS-19441) and a postdoctoral fellowship (to U.V.S.) from the American Heart Association, Florida Affiliate
UV Shenoy, EM Richards, XC Huang, C Sumners |
Endocrinology | 1999 |
AT1-Rezeptorblockade
P Dominiak, G Heusch |
1999 | |
Molecular Cardiology in Clinical Practice
M Sanders, JB Kostis |
1999 | |
Hormones and the Heart in Health and Disease
L Share |
1999 | |
Angiotensin II AT1-Rezeptorantagonisten
P Dominiak, T Unger |
1999 | |
Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108–15 Cells
L Gendron, L Laflamme, N Rivard, C Asselin, MD Payet, N Gallo-Payet |
Molecular Endocrinology | 1999 |
Comparative Safety and Tolerability of Angiotensin II Receptor Antagonists:
L Mazzolai, M Burnier |
Drug Safety | 1999 |
Characterization of AT2 receptor expression in NIH 3T3 fibroblasts
F M Heemskerk, S Zorad, N Xu, S J Gutkind, J M Saavedra |
Cellular and Molecular Neurobiology | 1999 |
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects
H Masaki, T Kurihara, A Yamaki, N Inomata, Y Nozawa, Y Mori, S Murasawa, K Kizima, K Maruyama, M Horiuchi, VJ Dzau, H Takahashi, T Iwasaka, M Inada, H Matsubara |
Journal of Clinical Investigation | 1998 |
Modulation of AT1receptor-mediated contraction of rat uterine artery by AT2receptors
AS Zwart, EA Davis, RE Widdop |
British Journal of Pharmacology | 1998 |
Das Renin-Angiotensin-System bei kardiovaskulären Erkrankungen
C Unterberg, H Kreuzer, AB Buchwald |
Medizinische Klinik | 1998 |
Inhibitory Effects of a Subdepressor Dose of L-158,809, an Angiotensin II Type 1 Receptor Antagonist, on Cardiac Hypertrophy and Nephropathy Via the Activated Human Renin-Angiotensin System in Double Transgenic Mice With Hypertension
T Kai, K Sugimura, S Shimada, A Kurooka, T Takenaka, K Ishikawa |
Japanese Circulation Journal | 1998 |
Does Blockade of Angiotensin II Receptors Offer Clinical Benefits over Inhibition of Angiotensin-Converting Enzyme?
M Gasparo, N Levens |
Pharmacology & Toxicology | 1998 |
Combination of ACE Inhibitors and Calcium Antagonists: A Logical Approach
FT Ruschitzka, G Noll, TF Lüscher |
Journal of Cardiovascular Pharmacology | 1998 |
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs
A Jalowy, R Schulz, H Dörge, M Behrends, G Heusch |
Journal of the American College of Cardiology | 1998 |
Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys
K Song, N Shiota, S Takai, H Takashima, H Iwasaki, S Kim, M Miyazaki |
Atherosclerosis | 1998 |
Pituitary-dependent expression of the testicular angiotensin II receptor and its subtypes in rats
HIRAI, SONG, KANEHARA, SHIOTA, UEDA, KIM, MIYAZAKI, KATSUOKA, MIYAZAKI |
International Journal of Andrology | 1998 |
The biochemical and physiological characteristics of receptors
EP Feener, GL King |
Advanced Drug Delivery Reviews | 1998 |
Replacement of Ace-Inhibitors by AII-Receptor Antagonists in Hypertensive Patients with Type H Diabetes Mellitus: Metabolic and Hemodynamic Consequences
J der Meulen, JP van der Sluijs, TJ Cleophas, AH Zwinderman |
Clinical Research and Regulatory Affairs | 1998 |
Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Rapid Communication
J Ma, H Nishimura, A Fogo, V Kon, T Inagami, I Ichikawa |
Kidney International | 1998 |
Bioelectronic noses: a status report. Part II1Co-ordinating authors: Ch. Ziegler and W. Göpel. All other authors are contributing authors.1
C Ziegler, W Göpel, H Hämmerle, H Hatt, G Jung, L Laxhuber, HL Schmidt, S Schütz, F Vögtle, A Zell |
Biosensors and Bioelectronics | 1998 |
Angiotensin II antagonists
RD Smith, G Cunningham, SD Kivlighn |
Expert Opinion on Emerging Drugs | 1998 |
Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats
B Gigante, O Piras, PD Paolis, A Porcellini, A Natale, M Volpe |
Journal of Hypertension | 1998 |
Localization and interactions of vasoactive peptide receptors in renomedullary interstitial cells of the kidney
J Zhuo, R Dean, C Maric, PG Aldred, P Harris, D Alcorn, FA Mendelsohn |
Kidney International | 1998 |
Physiological and pharmacological implications of AT1 versus AT2 receptors
O Chung, H Kuhl, M Stoll, T Unger |
Kidney International | 1998 |
Life and Death in the Microcirculation: a Role for Angiotensin II
AS Greene |
Microcirculation | 1998 |
EFFECT OF ANGIOTENSIN II RECEPTOR BLOCKADE ON THE INTERACTION BETWEEN ENALAPRILAT AND DOXAZOSIN IN RAT TAIL ARTERIES
JF Marwood |
Clinical and Experimental Pharmacology and Physiology | 1998 |
The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats
R Lucius, S Gallinat, P Rosenstiel, T Herdegen, J Sievers, T Unger |
Journal of Experimental Medicine | 1998 |
Modulation of the Vascular Smooth Muscle Angiotensin Subtype 2 (AT2) Receptor by Angiotensin II
P Zahradka, L Yau, C Lalonde, J Buchko, S Thomas, J Werner, M Nguyen, L Saward |
Biochemical and Biophysical Research Communications | 1998 |
Angiotensin AT2Receptor Degradation Is Prevented by Ligand Occupation
T Csikós, AJ Balmforth, M Grojec, P Gohlke, J Culman, T Unger |
Biochemical and Biophysical Research Communications | 1998 |
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study
T Yamada, M Akishita, MJ Pollman, GH Gibbons, VJ Dzau, M Horiuchi |
Life Sciences | 1998 |
The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors
G Servant, E Escher, G Guillemette |
Regulatory Peptides | 1998 |
Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand–receptor interaction
L Pulakat, AS Tadessee, JJ Dittus, N Gavini |
Regulatory Peptides | 1998 |
The Angiotensin II Type 2 (AT2) Receptor Promotes Axonal Regeneration in the Optic Nerve of Adult Rats
R Lucius, S Gallinat, P Rosenstiel, T Herdegen, J Sievers, T Unger |
Journal of Experimental Medicine | 1998 |
Advances in Organ Biology
AJ Liedtke |
Advances in Organ Biology | 1998 |
Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves
S Gallinat, M Yu, A Dorst, T Unger, T Herdegen |
Molecular Brain Research | 1998 |
Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression
Y Tsutsumi, H Matsubara, N Ohkubo, Y Mori, Y Nozawa, S Murasawa, K Kijima, K Maruyama, H Masaki, Y Moriguchi, Y Shibasaki, H Kamihata, M Inada, T Iwasaka |
Circulation research | 1998 |
The Relevance of T-Type Calcium Antagonists: A Profile of Mibefradil
SP Glasser |
The Journal of Clinical Pharmacology | 1998 |
Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
A Otani, H Takagi, K Suzuma, Y Honda |
Circulation research | 1998 |
Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide
T Ichiki, M Usui, M Kato, Y Funakoshi, K Ito, K Egashira, A Takeshita |
Hypertension | 1998 |
Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II
W Huang, FA Gelas, MJ Osborne-Pellegrin |
Laboratory Investigation | 1998 |
Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells
A Tanabe, M Naruse, K Arai, K Naruse, T Yoshimoto, T Seki, T Imaki, M Kobayashi, H Miyazaki, H Demura |
Journal of Endocrinological Investigation | 1998 |
Angiotensin-converting Enzyme Inhibition Delays Pulmonary Vascular Neointimal Formation
K Okada, ML Bernstein, W Zhang, DP Schuster, MD Botney |
American journal of respiratory and critical care medicine | 1998 |
Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells: Expression of Transcription Factors and Transforming Growth Factor- β 1
S McKay, JC de Jongste, PR Saxena, HS Sharma |
American journal of respiratory cell and molecular biology | 1998 |
AngiotensinII and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor
U Stroth, S Meffert, S Gallinat, T Unger |
Molecular Brain Research | 1998 |
Angiotensin II Delivery and Binding at the Microvascular Endothelium and Cardiac Myocyte Surfaces in Perfused Rat Hearts
AB Bikhazi, RE Haddad, ZA Nahle, KM Bitar |
Journal of Pharmaceutical Sciences | 1998 |
Vascular Remodeling—The Emerging Paradigm of Programmed Cell Death (Apoptosis)
VJ Dzau, M Horiuchi |
Chest | 1998 |
Molecular and cellular mechanism of angiotensin II-mediated apoptosis
M Horiuchi, M Akishita, VJ Dzau |
Endocrine Research | 1998 |
Chronic administration of furosemide augments renal weight and glomerular capillary pressure in normal rats
PH Lane, LD Tyler, PG Schmitz |
American journal of physiology. Renal physiology | 1998 |
Nephrogenesis and angiotensin II receptor subtypes gene expression in the fetal lamb
V Gimonet, L Bussieres, AA Medjebeur, B Gasser, B Lelongt, K Laborde |
American journal of physiology. Renal physiology | 1998 |
Ablation of lung endothelial injury after pacing-induced heart failure is related to alterations in Ca 2+ signaling
CL Ivey, BJ Roy, MI Townsley |
American journal of physiology. Heart and circulatory physiology | 1998 |
PDGF-BB-induced DNA synthesis is delayed by angiotensin II in vascular smooth muscle cells
G Dahlfors, Y Chen, M Wasteson, HJ Arnqvist |
American journal of physiology. Heart and circulatory physiology | 1998 |
Autoradiographic Localization and Characterization of Angiotensin II Receptors in the Bovine Placenta and Fetal Membranes1
KH Schauser, AH Nielsen, H Winther, V Dantzer, K Poulsen |
Biology of reproduction | 1998 |
Role of AT 1 and AT 2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes
TA Fischer, K Singh, DS OHara, DM Kaye, RA Kelly |
American journal of physiology. Heart and circulatory physiology | 1998 |
Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle
EH Nora, DH Munzenmaier, FM Hansen-Smith, JH Lombard, AS Greene |
American journal of physiology. Heart and circulatory physiology | 1998 |
Localization of the mRNA for the Angiotensin II Receptor Subtype 2 (AT2) in Follicular Granulosa Cells of the Rat Ovary by Nonradioactive In Situ Hybridization
N Obermüller, D Schlamp, S Hoffmann, M Gentili, T Inagami, N Gretz, M Weigel |
Journal of Histochemistry & Cytochemistry | 1998 |
Immunolocalization of Subtype 2 Angiotensin II (AT 2 ) Receptor Protein in Rat Heart
ZQ Wang, AF Moore, R Ozono, HM Siragy, RM Carey |
Hypertension | 1998 |
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
H Matsubara |
Circulation research | 1998 |
Differential Effects of Angiotensin II on Cardiac Cell Proliferation and Intramyocardial Perivascular Fibrosis In Vivo
PE McEwan, GA Gray, L Sherry, DJ Webb, CJ Kenyon |
Circulation | 1998 |
Vasodepressor Actions of Angiotensin-(1–7) Unmasked During Combined Treatment With Lisinopril and Losartan
SN Iyer, MC Chappell, DB Averill, DI Diz, CM Ferrario |
Hypertension | 1998 |
Angiotensin II Receptor Blockade Physiological and Clinical Implications
NS Dhalla, P Zahradka, IM Dixon, RE Beamish |
1998 | |
Oleic Acid and Angiotensin II Induce a Synergistic Mitogenic Response in Vascular Smooth Muscle Cells
G Lu, KE Meier, AA Jaffa, SA Rosenzweig, BM Egan |
Hypertension | 1998 |
Early Impairment of Renal Hemodynamic Reserve in Patients With Asymptomatic Heart Failure Is Restored by Angiotensin II Antagonism
P Magri, MA Rao, S Cangianiello, V Bellizzi, R Russo, AF Mele, M Andreucci, B Memoli, LD Nicola, M Volpe |
Circulation | 1998 |
Effects of AT 1 and AT 2 Angiotensin Receptor Antagonists in Angiotensin II-Infused Rats
JS Li, RM Touyz, EL Schiffrin |
Hypertension | 1998 |
AT 2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
P Gohlke, C Pees, T Unger |
Hypertension | 1998 |
Expression of Functional Angiotensin-Converting Enzyme and AT 1 Receptors in Cultured Human Cardiac Fibroblasts
S Hafizi, J Wharton, K Morgan, SP Allen, AH Chester, JD Catravas, JM Polak, MH Yacoub |
Circulation | 1998 |
Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodeling in Spontaneously Hypertensive Rats
S Otsuka, M Sugano, N Makino, S Sawada, T Hata, Y Niho |
Hypertension | 1998 |
Herz-Kreislauf-Erkrankungen
D Ganten, K Ruckpaul |
1998 | |
Endocrinology of Cardiovascular Function
ER Levin, JL Nadler |
1998 | |
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors
YH Liu, XP Yang, VG Sharov, O Nass, HN Sabbah, E Peterson, OA Carretero |
Journal of Clinical Investigation | 1997 |
Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor
G Wolf, FN Ziyadeh, F Thaiss, J Tomaszewski, RJ Caron, U Wenzel, G Zahner, U Helmchen, RA Stahl |
Journal of Clinical Investigation | 1997 |
Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole
S Arima, Y Endo, H Yaoita, K Omata, S Ogawa, K Tsunoda, M Abe, K Takeuchi, K Abe, S Ito |
Journal of Clinical Investigation | 1997 |
Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
T Oikawa, M Freeman, W Lo, DE Vaughan, A Fogo |
Kidney International | 1997 |
The antiatherogenic potential of blocking the renin-angiotensin system
RM Goetz |
Expert Opinion on Investigational Drugs | 1997 |
The Role of Angiotensin Receptors in Cardiovascular Diseases
K Helin, M Stoll, S Meffert, U Stroth, T Linger |
Annals of Medicine | 1997 |
Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma
DA Walsh, DE Hu, J Wharton, JD Catravas, DR Blake, TP Fan |
British Journal of Pharmacology | 1997 |
Angiotensin II receptor antagonists - antihypertensive agents
M Burnier, HR Brunner |
Expert Opinion on Investigational Drugs | 1997 |
Effects of Hypercholesterolemia on the Contractions to Angiotensin II in the Isolated Aorta and Iliac Artery of the Rabbit: Role of Arachidonic Acid Metabolites
JP Dam, W Vleeming, J Riezebos, MJ Post, AJ Porsius, J Wemer |
Journal of Cardiovascular Pharmacology | 1997 |
Structural adaptation to ischemia in skeletal muscle
KJ Scheidegger, MH Nelissen-Vrancken, PJ Leenders, MJ Daemen, JF Smits, JM Wood |
Journal of Hypertension | 1997 |
Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension
M McIntyre, SE Caffe, RA Michalak, JL Reid |
Pharmacology & Therapeutics | 1997 |
Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling
CH Gelband, C Sumners, D Lu, MK Raizada |
Regulatory Peptides | 1997 |
Pharmacological Demonstration of the Additive Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism in Sodium Depleted Healthy Subjects
M Azizi, TT Guyene, G Chatellier, J Ménard |
Clinical and Experimental Hypertension | 1997 |
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
K Bedecs, N Elbaz, M Sutren, M Masson, C Susini, AD Strosberg, C Nahmias |
Biochemical Journal | 1997 |
ACE Inhibition Accelerates Endothelial Regrowthin Vivo:A Possible Explanation for the Benefit Observed with ACE Inhibitors Following Arterial Injury
EV Belle, T Meurice, FO Tio, D Corseaux, B Dupuis, EP McFadden, JM Lablanche, C Bauters, ME Bertrand |
Biochemical and Biophysical Research Communications | 1997 |
Dose-dependent inhibitory effects of angiotensin II on visual responses of the rat superior colliculus: AT1 and AT2 receptor contributions
L Merabet |
Neuropeptides | 1997 |
The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells
S Gallinat |
Neuroscience Letters | 1997 |
Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II AT1 Receptor Antagonism on Cardiac Parameters in Left Ventricular Hypertrophy
YC MD, YZ MD, PG PhD, HM MD, TU MD |
The American Journal of Cardiology | 1997 |
Angiotensin II receptors in endothelial cells
ME Pueyo, JB Michel |
General Pharmacology: The Vascular System | 1997 |
Is there a rationale for combining angiotensinconverting enzyme inhibitors and calcium antagonists in cardiovascular disease?
FT Ruschitzka, TF Lüscher |
American Heart Journal | 1997 |
Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
J Ménard, DJ Campbell, M Azizi, MF Gonzales |
Circulation | 1997 |
Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide
S Dimmeler, V Rippmann, U Weiland, J Haendeler, AM Zeiher |
Circulation research | 1997 |
The Kinin System
A Schmaier |
The Kinin System | 1997 |
Cardiac angiotensin II receptors: studies on functional coupling in Sprague-Dawley rats and TGR(αMHC-hAT1) transgenic rats
S Rosenkranz, G Nickenig, M Flesch, B Cremers, P Schnabel, O Lenz, T Krause, D Ganten, S Hoffmann, M Böhm |
European Journal of Pharmacology | 1997 |
Angiotensin type-1 (AT1) receptor gene expression in primarily cultured human arterial umbilical endothelial cells
Y Ko, B Glodny, S Stier, G Totzke, G Nickenig, R Düsing, A Sachinidis, H Vetter |
Biochemical Pharmacology | 1997 |
Angiotensin II type-2 (AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells
WR Schelman, JL Kurth, RL Berdeaux, SW Norby, JA Weyhenmeyer |
Molecular Brain Research | 1997 |
Angiotensin II type-I receptor antagonists in the treatment of heart failure
MG Nicholls, IG Crozier, H Ikram, AM Richards |
International Journal of Cardiology | 1997 |
Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
N Ohkubo, H Matsubara, Y Nozawa, Y Mori, S Murasawa, K Kijima, K Maruyama, H Masaki, Y Tsutumi, Y Shibazaki, T Iwasaka, M Inada |
Circulation | 1997 |
Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells
G Wolf, KJ Assmann, RA Stahl |
Kidney International | 1997 |
Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells
PK Chatterjee, RP Weerackody, SK Mistry, GM Hawksworth, JS Mclay |
Kidney International | 1997 |
Angiotensin Type 2 Receptor Dephosphorylates Bcl-2 by Activating Mitogen-activated Protein Kinase Phosphatase-1 and Induces Apoptosis
M Horiuchi, W Hayashida, T Kambe, T Yamada, VJ Dzau |
The Journal of biological chemistry | 1997 |
Interferon Regulatory Factor-1 Up-regulates Angiotensin II Type 2 Receptor and Induces Apoptosis
M Horiuchi, T Yamada, W Hayashida, VJ Dzau |
The Journal of biological chemistry | 1997 |
ANG II AT 1 and AT 2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells
P Liakos, N Bourmeyster, G Defaye, EM Chambaz, SP Bottari |
American journal of physiology. Cell physiology | 1997 |
Modulation of angiotensin II type 2 receptor mRNA in rat hypothalamus and brainstem neuronal cultures by growth factors
XC Huang, UV Shenoy, EM Richards, C Sumners |
Brain research. Molecular brain research | 1997 |
Identification of Angiotensin II-binding Domains in the Rat AT 2 Receptor with Photolabile Angiotensin Analogs
G Servant, SA Laporte, R Leduc, E Escher, G Guillemette |
The Journal of biological chemistry | 1997 |
Growth-Dependent Induction of Angiotensin II Type 2 Receptor in Rat Mesangial Cells
M Goto, M Mukoyama, S Suga, T Matsumoto, M Nakagawa, R Ishibashi, M Kasahara, A Sugawara, I Tanaka, K Nakao |
Hypertension | 1997 |
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
N Makino, M Sugano, S Otsuka, T Hata |
Hypertension | 1997 |
Additive Effects of Losartan and Enalapril on Blood Pressure and Plasma Active Renin
M Azizi, TT Guyene, G Chatellier, M Wargon, J Ménard |
Hypertension | 1997 |
Differential Roles of AT 1 and AT 2 Receptor Subtypes in Vascular Trophic and Phenotypic Changes in Response to Stimulation With Angiotensin II
A Sabri, BI Levy, P Poitevin, L Caputo, E Faggin, F Marotte, L Rappaport, JL Samuel |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
S Kim, H Wanibuchi, A Hamaguchi, K Miura, S Yamanaka, H Iwao |
Hypertension | 1997 |
Effects of Angiotensin II on Cardiac Function and Peripheral Vascular Structure During Compensated Heart Failure in the Rat
S Heeneman, JF Smits, PJ Leenders, PM Schiffers, MJ Daemen |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Expression of the Subtype 2 Angiotensin (AT 2 ) Receptor Protein in Rat Kidney
R Ozono, ZQ Wang, AF Moore, T Inagami, HM Siragy, RM Carey |
Hypertension | 1997 |
Load-Induced Growth Responses in Isolated Adult Rat Hearts: Role of the AT 1 Receptor
CD Thienelt, EO Weinberg, J Bartunek, BH Lorell |
Circulation | 1997 |
Hypertension and the Heart
A Zanchetti, RB Devereux, L Hansson, S Gorini |
1997 | |
Angiotensin II–Induced Leukocyte Adhesion on Human Coronary Endothelial Cells Is Mediated by E-Selectin
M Gräfe, W Auch-Schwelk, A Zakrzewicz, V Regitz-Zagrosek, P Bartsch, K Graf, M Loebe, P Gaehtgens, E Fleck |
Circulation research | 1997 |
Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats
A Benetos, BI Levy, P Lacolley, F Taillard, M Duriez, ME Safar |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Endogenous Angiotensin II Produced by Endothelium Regulates Interleukin-1β–Stimulated Nitric Oxide Generation in Rat Isolated Vessels
M Montón, A López-Farré, JR Mosquera, LS de Miguel, M García-Durán, MP Sierra, T Bellver, L Rico, S Casado |
Hypertension | 1997 |
Bovine Aortic Endothelial Cells Contain an Angiotensin-(1–7) Receptor
EA Tallant, X Lu, RB Weiss, MC Chappell, CM Ferrario |
Hypertension | 1997 |
AT 1 and AT 2 Angiotensin Receptor Gene Expression in Human Heart Failure
GA Haywood, L Gullestad, T Katsuya, HG Hutchinson, RE Pratt, M Horiuchi, MB Fowler |
Circulation | 1997 |
Blockade of Bradykinin B 2 Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats
P Gohlke, I Kuwer, A Schnell, K Amann, G Mall, T Unger |
Hypertension | 1997 |
Endothelial Function in Hypertension
D Webb, P Vallance |
1997 | |
Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo
D Jin, K Song, Y Oka, S Takai, N Shiota, M Miyazaki |
The Japanese Journal of Pharmacology | 1997 |
Vasculoprotective and Cardioprotective Mechanisms of Angiotensin‐Converting Enzyme Inhibition: The Homeostatic Balance Between Angiotensin II and Nitric Oxide
GH Gibbons |
Clinical Cardiology | 1997 |
Contribution of Bradykinin to the Cardioprotective Action of Angiotensin Converting Enzyme Inhibition in Hypertension and After Myocardial Infarction
K Ito, YZ Zhu, YC Zhu, P Gohlke, T Unger |
The Japanese Journal of Pharmacology | 1997 |
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure
BI Levy, J Benessiano, D Henrion, L Caputo, C Heymes, M Duriez, P Poitevin, JL Samuel |
Journal of Clinical Investigation | 1996 |
Vasoactive hormones and renal sclerosis
J Egido |
Kidney International | 1996 |
Adrenaline cells of the rat adrenal cortex and medulla contain renin and prorenin
JL Berka, DJ Kelly, DB Robinson, D Alcorn, PD Marley, RT Fernley, SL Skinner |
Molecular and Cellular Endocrinology | 1996 |
DOWN-REGULATION OF ANGIOTENSIN II RECEPTORS IN HYPERTROPHIED HUMAN MYOCARDIUM
Y Nozawa, H Miyake, A Haruno, S Yamada, S Uchida, T Ohkura, R Kimura, H Suzuki, T Hoshino |
Clinical and Experimental Pharmacology and Physiology | 1996 |
Calcium channel diversity in the cardiovascular system
AM Katz |
Journal of the American College of Cardiology | 1996 |
Insulin and Insulin-Like Growth Factors Induce Expression of Angiotensin Type-2 Receptor in Vascular-Smooth-Muscle Cells
Y Kambayashi, K Nagata, T Ichiki, T Inagami |
European Journal of Biochemistry | 1996 |
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells
S Meffert, M Stoll, UM Steckelings, SP Bottari, T Unger |
Molecular and Cellular Endocrinology | 1996 |
Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: PRESENCE OF ANGIOTENSIN II AT2 RECEPTOR BINDING SITES IN THE ADVENTITIA OF HUMAN KIDNEY VASCULATURE
J Zhuo, R Dean, D MacGregor, D Alcorn, FA Mendelsohn |
Clinical and Experimental Pharmacology and Physiology | 1996 |
Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: ENDOGENOUS ANGIOTENSIN II LEVELS AND THE MECHANISM OF ACTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR TYPE 1 ANTAGONISTS
DJ Campbell |
Clinical and Experimental Pharmacology and Physiology | 1996 |
Issue-specific Regulation of Angiotensin-Converting Enzyme by Angiotensin II and Losartan in the Rat
KP Metsaurinne, KH Helin, O Saijonmaa, P Stewen, ML Ousirvi, FY Fyhrquist |
Blood Pressure | 1996 |
Is there an internal cardiac renin-angiotensin system?
AH Danser, MA Schalekamp |
Heart (British Cardiac Society) | 1996 |
Early expression of all the components of the renin-angiotensin-system in human development
S Schütz, JM le Moullec, P Corvol, JM Gasc |
The American Journal of Pathology | 1996 |
Renin angiotensin system in development of mice and men
A Fogo, I Ichikawa |
The American Journal of Pathology | 1996 |
Angiotensin II type 2 receptor mediates programmed cell death
T Yamada, M Horiuchi, VJ Dzau |
Proceedings of the National Academy of Sciences | 1996 |
Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model
DE Hu, CR Hiley, TP Fan |
British Journal of Pharmacology | 1996 |
Angiotensin II-elicited signal transduction via AT1 receptors in endothelial cells
ME Pueyo, N N'Diaye, JB Michel |
British Journal of Pharmacology | 1996 |
Neuroendocrine activation after myocardial infarction: causes and consequences
JG Cleland, PJ Cowburn, K Morgan |
Heart (British Cardiac Society) | 1996 |
The renin-angiotensin system and the heart: beyond 2000
T Morgan, HR Brunner |
Heart (British Cardiac Society) | 1996 |
The Renin-Angiotensin System in the Rabbit Eye
M Ramirez, EA Davidson, L Luttenauer, PP Elena, F Cumin, GA Mathis, MD Gasparo |
Journal of Ocular Pharmacology and Therapeutics | 1996 |
Angiotensin Receptors and Their Antagonists
AJ Wood, TL Goodfriend, ME Elliott, KJ Catt |
New England Journal of Medicine | 1996 |
Localization and quantitation of angiotensin AT1 and AT2 receptors in the pregnant and non-pregnant sheep uterus
I Moeller, SY Chai, DP MacGregor, GP Aldred, FA Mendelsohn |
Regulatory Peptides | 1996 |
Protein Families That Mediate Ca2+ Signaling in the Cardiovascular System
AM Katz |
The American Journal of Cardiology | 1996 |
Drug Evaluations Cardiovascular & Renal: Biology of angiotensin II receptor inhibition with a focus on losartan: A new drug for the treatment of hypertension
EA Tallant, CM Ferrario |
Expert Opinion on Investigational Drugs | 1996 |
Mitogen-activated Protein Kinases in Rat Brain Neuronal Cultures Are Activated by Angiotensin II Type 1 Receptors and Inhibited by Angiotensin II Type 2 Receptors
XC Huang, EM Richards, C Sumners |
The Journal of biological chemistry | 1996 |
Angiotensin II Induction of Neurite Outgrowth by AT 2 Receptors in NG108-15 Cells: EFFECT COUNTERACTED BY THE AT 1 RECEPTORS
L Laflamme, M Gasparo, JM Gallo, MD Payet, N Gallo-Payet |
The Journal of biological chemistry | 1996 |
What can angiotensin antagonists do that converting-enzyme inhibition can't: the case of post-angioplastic restenosis
D Pham, S Laporte, J Pérodin, R Bourgeois, E Escher |
Canadian Journal of Physiology and Pharmacology | 1996 |
Intracellular Third Loop Domain of Angiotensin II Type-2 Receptor: ROLE IN MEDIATING SIGNAL TRANSDUCTION AND CELLULAR FUNCTION
W Hayashida, M Horiuchi, VJ Dzau |
The Journal of biological chemistry | 1996 |
Angiotensin II Type 2 Receptor Inhibits Cell Proliferation and Activates Tyrosine Phosphatase
S Tsuzuki, T Matoba, S Eguchi, T Inagami |
Hypertension | 1996 |
Angiotensin II Is Mitogenic for Cultured Rat Glomerular Endothelial Cells
G Wolf, FN Ziyadeh, G Zahner, RA Stahl |
Hypertension | 1996 |
Mechanical Stretch Induces Enhanced Expression of Angiotensin II Receptor Subtypes in Neonatal Rat Cardiac Myocytes
K Kijima, H Matsubara, S Murasawa, K Maruyama, Y Mori, N Ohkubo, I Komuro, Y Yazaki, T Iwasaka, M Inada |
Circulation research | 1996 |
In Vivo Gene Transfer and Gene Modulation in Hypertension Research
VJ Dzau, M Horiuchi |
Hypertension | 1996 |
Cardiac and Vascular Effects of Long-term Losartan Treatment in Stroke-Prone Spontaneously Hypertensive Rats
P Gohlke, W Linz, BA Schölkens, G Wiemer, T Unger |
Hypertension | 1996 |
Chronic α 1 -Adrenoreceptor Stimulation Increases DNA Synthesis in Rat Arterial Wall: Modulation of Responsiveness After Vascular Injury
D deBlois, SM Schwartz, EM van Kleef, JE Su, KA Griffin, AK Bidani, MJ Daemen, DM Lombardi |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
DH Munzenmaier, AS Greene |
Hypertension | 1996 |
Vascular Smooth Muscle Polyploidy and Cardiac Hypertrophy in Genetic Hypertension
AF Dominiczak, AM Devlin, WK Lee, NH Anderson, DF Bohr, JL Reid |
Hypertension | 1996 |
Angiotensin II Type 2 Receptor Subtype Mediates Phospholipase A 2 –Dependent Signaling in Rabbit Proximal Tubular Epithelial Cells
LS Jacobs, JG Douglas |
Hypertension | 1996 |
Pharmacological Strategies to Prevent Restenosis: Lessons Learned From Blockade of the Renin-Angiotensin System
RE Pratt, VJ Dzau |
Circulation | 1996 |
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
EJ Freeman, GM Chisolm, CM Ferrario, EA Tallant |
Hypertension | 1996 |
Role of Type 1 and Type 2 Angiotensin Receptors in Angiotensin II–Induced Cardiomyocyte Hypertrophy
GW Booz, KM Baker |
Hypertension | 1996 |
Postischemic Antiarrhythmic Effects of Angiotensin-Converting Enzyme Inhibitors: Role of Suppression of Endogenous Endothelin Secretion
F Brunner, WR Kukovetz |
Circulation | 1996 |
Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors
MK Raizada, MI Phillips, C Sumners |
1996 | |
The cellular basis of angiotensin converting enzyme mRNA expression in rat heart
M Paul, M Stoll, R Kreutz, MS Fernandez-Alfonso |
Basic Research in Cardiology | 1996 |
Subtype 2 and atypical angiotensin receptors in the human heart
V Regitz-Zagrosek, M Neu, C Warnecke, J Holzmeister, AG Hildebrandt, E Fleck |
Basic Research in Cardiology | 1996 |
ACE Inhibitors and the Kidney: A Risk-Benefit Assessment
G Navis, HJ Faber, D de Zeeuw, PE de Jong |
Drug Safety | 1996 |
Molecular biology of angiotensin receptors and their role in human cardiovascular disease
V Regitz-Zagrosek, M Neuß, J Holzmeister, C Warnecke, E Fleck |
Journal of Molecular Medicine | 1996 |
The renin-angiotensin-system in the skin. Evidence for its presence and possible functional implications
UM Steckelings, BM Czarnelzki |
Experimental Dermatology | 1995 |
Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors
YC Zhu, HM Stauss, G Bao, P Gohlke, YZ Zhu, T Redlich, T Unger |
Canadian Journal of Physiology and Pharmacology | 1995 |
The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function
C Nahmias, AD Strosberg |
Trends in Pharmacological Sciences | 1995 |
Angiotensin Receptors in the Brain
S Höhle, A Blume, C Lebrun, J Culman, T Unger |
Pharmacology & Toxicology | 1995 |
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer
M Nakajima, HG Hutchinson, M Fujinaga, W Hayashida, R Morishita, L Zhang, M Horiuchi, RE Pratt, VJ Dzau |
Proceedings of the National Academy of Sciences | 1995 |
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors
M Mukoyama, M Nakajima, M Horiuchi, H Sasamura, RE Pratt, VJ Dzau, KM Curnow |
Journal of Endocrinological Investigation | 1995 |
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
T Ichiki, PA Labosky, C Shiota, S Okuyama, Y Imagawa, A Fogo, F Niimura, I Ichikawa, BL Hogan, T lnagami |
Nature | 1995 |
Cloning, Characterization, and Genetic Mapping of the Rat Type 2 Angiotensin II Receptor Gene
G Koike, ES Winer, M Horiuchi, DM Brown, C Szpirer, VJ Dzau, HJ Jacob |
Hypertension | 1995 |
Endothelial AT 1 –Mediated Release of Nitric Oxide Decreases Angiotensin II Contractions in Rat Carotid Artery
CM Boulanger, L Caputo, BI Lévy |
Hypertension | 1995 |
Characterization and Functional Analysis of the Rat Endothelin-1 Promoter
M Paul, M Zintz, W Böcker, M Dyer |
Hypertension | 1995 |
Multiple Growth Factors Modulate mRNA Expression of Angiotensin II Type-2 Receptor in R3T3 Cells
T Ichiki, Y Kambayashi, T Inagami |
Circulation research | 1995 |